Skip to main content
eLife logoLink to eLife
. 2022 Jul 15;11:e64329. doi: 10.7554/eLife.64329

Age and diet shape the genetic architecture of body weight in diversity outbred mice

Kevin M Wright 1,, Andrew G Deighan 2, Andrea Di Francesco 1, Adam Freund 1, Vladimir Jojic 1, Gary A Churchill 2,, Anil Raj 1,†,
Editors: Sara Hägg3, Naama Barkai4
PMCID: PMC9286741  PMID: 35838135

Abstract

Understanding how genetic variation shapes a complex trait relies on accurately quantifying both the additive genetic and genotype–environment interaction effects in an age-dependent manner. We used a linear mixed model to quantify diet-dependent genetic contributions to body weight measured through adulthood in diversity outbred female mice under five diets. We observed that heritability of body weight declined with age under all diets, except the 40% calorie restriction diet. We identified 14 loci with age-dependent associations and 19 loci with age- and diet-dependent associations, with many diet-dependent loci previously linked to neurological function and behavior in mice or humans. We found their allelic effects to be dynamic with respect to genomic background, age, and diet, identifying several loci where distinct alleles affect body weight at different ages. These results enable us to more fully understand and predict the effectiveness of dietary intervention on overall health throughout age in distinct genetic backgrounds.

Research organism: Mouse

eLife digest

Body weight is one trait influenced by genes, age and environmental factors. Both internal and external environmental pressures are known to affect genetic variation over time. However, it is largely unknown how all factors – including age – interact to shape metabolism and bodyweight.

Wright et al. set out to quantify the interactions between genes and diet in ageing mice and found that the effect of genetics on mouse body weight changes with age. In the experiments, Wright et al. weighed 960 female mice with diverse genetic backgrounds, starting at two months of age into adulthood. The animals were randomized to different diets at six months of age. Some mice had unlimited food access, others received 20% or 40% less calories than a typical mouse diet, and some fasted one or two days per week.

Variations in their genetic background explained about 80% of differences in mice’s weight, but the influence of genetics relative to non-genetic factors decreased as they aged. Mice on the 40% calorie restriction diet were an exception to this rule and genetics accounted for 80% of their weight throughout adulthood, likely due to reduced influence from diet and reduced interactions between diet and genes. Several genes involved in metabolism, neurological function, or behavior, were associated with mouse weight.

The experiments highlight the importance of considering interactions between genetics, environment, and age in determining complex traits like body weight. The results and the approaches used by Wright et al. may help other scientists learn more about how the genetic predisposition to disease changes with environmental stimuli and age.

Introduction

Quantifying the contributions of genetic and environmental factors to population variation in an age-dependent phenotype is critical to understanding how phenotypes change over time and in response to external perturbations. The identification of genetic loci that are associated with a complex trait in an age- and environment-dependent manner allows us to elucidate the dynamics and context dependence of the genetic architecture of the trait and facilitates trait prediction. For health-related traits, these genetic loci may also facilitate greater understanding and prediction of age-related disease etiology, which is an important step to genetically or pharmacologically manipulating these traits to improve health.

Standard approaches used to identify genetic loci associated with quantitative traits can be confounded by nonadditive genetic effects such as genotype–environment (G×E) and genotype–age (G×A) interactions (Robinson et al., 2017), contributing to the ‘missing heritability’ of quantitative traits (Sul et al., 2016). The linear statistical models routinely used in genetic mapping analyses do not account for variation in population structure between environments and polygenicity in G×E interactions. Population structure can substantially increase the false-positive rate when testing for G×E associations (Moore et al., 2019). Furthermore, not accounting for polygenic G×E interactions has the potential to incorrectly estimate the heritability of quantitative traits in the context of specific environments (Sul et al., 2016). To address these limitations, recent efforts have generalized standard linear mixed models (LMMs) with multiple variance components that allow for polygenic G×E interactions and environment-dependent residual variation (Sul et al., 2016; Runcie and Crawford, 2019; Moore et al., 2019; Dahl et al., 2020). Moreover, these LMMs substantially increase the power to discover genomic loci that are associated with phenotype in both an environment-independent and environment-dependent manner.

In this study, we used an LMM to investigate the classic quantitative trait, body weight, in a large population of diversity outbred (DO) mice. Body weight was measured longitudinally from early development to late adulthood, before and after the imposition of dietary intervention at 6 months of age. We expect diet and age to be important factors affecting body weight and growth rate; however, it remains to be determined how these factors will interact with genetic variation to shape growth. Two early studies found significant genetic correlations for body weight and growth rate during the first 10 weeks of mouse development, which supported the hypothesis that growth rates during early and late development were affected by pleiotropic loci (Cheverud et al., 1996; Riska et al., 1984). Subsequent experiments found that the heritability of body weight increased monotonically with age throughout development: from 29.3% to 76.1% between 1 and 10 weeks of age (Cheverud et al., 1996), from 6% to 24% between 1 and 16 weeks of age (Gray et al., 2015), and from 9% to 32% between 5 and 13 weeks of age (Parker et al., 2016). The heritability of growth rate also varied with age, but exhibited a peak of 24% at 3 weeks of age and then declined to nearly 4% at 16 weeks of age (Gray et al., 2015). The strength of association and effect size of QTLs for body weight and growth rate were specific to early or late ages and were inconsistent with the hypothesis that pleiotropic alleles affect animal size at early and late developmental stages (Cheverud et al., 1996; Gray et al., 2015). While these results are well supported, their interpretation is somewhat limited because body weight measurements ceased at young ages and significant QTLs encompassed fairly large chromosomal regions. Given these limitations, we were motivated to ask two questions: Will fine-mapping to greater resolution reveal single genes that function at either early or late developmental stages, or reveal multiple genes in tight linkage with variable age-specific effects? How will the effect of these loci change at later ages and under different diets?

We expect the interaction of dietary interventions, such as calorie restriction (CR) or intermittent fasting (IF), with genetics to greatly impact the body weight trajectories of mice. Researchers have observed genotype-dependent reductions in body weight in the 7–50 weeks after imposing a 40% CR diet, and variation in heritability of this trait with age from 42% to 54% (Rikke et al., 2006). A second study subjected a large genetic-mapping population to dietary intervention and identified multiple loci with significant genetic and genotype–diet interaction effects on body weight at 2–6 months of age (Vorobyev et al., 2019). These studies identified substantial diet- and age-dependent genetic variance for body weight in mice, similar to what has been found in humans (Robinson et al., 2017; Couto Alves et al., 2019; Wang et al., 2019). It, however, remains to be determined how the contribution of specific genetic loci to body weight changes in response to different dietary interventions and whether the effects observed in younger mice are indicative of the maintenance of body weight in adult mice.

In order to address these questions, we measured the body weight of multiple cohorts of genetically diverse mice from the DO population (Svenson et al., 2012) from 60 to 660 days of age (Figure 1A). At 180 days of age, we randomized mice by body weight and assigned each mouse to one of five dietary regimes – ad libitum (AL), 20% and 40% daily CR, and 1 or 2 days per week IF. Longitudinal measurements of body weight in these DO mice allowed us to discover the age-dependent genetic determinants of body weight and growth rate in the context of different dietary interventions.

Figure 1. Study design and body weight data summaries.

(A) Outline of study design. (B) Median (interquartile range) body weight in grams and (C) median (interquartile range) growth rate in grams per day for five dietary treatments from 60 to 660 days of age. Vertical gray dotted line denotes the onset of dietary intervention at 180 days of age.

Figure 1.

Figure 1—figure supplement 1. Raw phenotype measurements.

Figure 1—figure supplement 1.

Body weight and growth rate trends as a function of age. Mice in this study also underwent an array of phenotyping procedures; the age range for metabolic cage phenotyping is highlighted in pink, the age range for blood draws is highlighted in blue, and the age range for a battery of challenge-based phenotyping procedures is highlighted in green.

In the following sections, we first describe the study design and collection of the genetic and body weight measurements. Second, we motivate the use of the gene–environment mixed model (G×EMM) (Dahl et al., 2020) to model genetic associations in these data and give an overview of our analyses. We next use this model to identify genetic loci having additive or genotype–diet interaction effects on body weight. We fine-map candidate loci and determine the scope of pleiotropy for age- and diet-specific effects. We find many, but not all, loci are associated with body weight in a narrow age range and localize to small genomic regions, in some cases to single genes. We utilize the full genome sequence of the DO founders and external chromatin accessibility data to further narrow the genomic regions to a small number of candidate variants at each locus. Interestingly, many diet-specific body weight loci localize genes implicated in neurological function and behavior in mice or humans.

Results and discussion

Study design and measurements

The DO house mouse (Mus musculus) population was derived from eight inbred founder strains and is maintained at Jackson Labs as an outbred heterozygous population (Svenson et al., 2012). This study contains 960 female DO mice, sampled at generations: 22–24 and 26–28. There were two cohorts per generation for a total of 12 cohorts and 80 animals per cohort. Enrollment occurred in successive quarterly waves starting in March 2016 and continuing through November 2017.

A single female mouse per litter was enrolled into the study after wean age (3 weeks old), so that no mice in the study were siblings and maximum genetic diversity was achieved. Mice were housed in pressurized, individually ventilated cages at a density of eight animals per cage (cage assignments were random). Mice were subject to a 12 hr:12 hr light:dark cycle beginning at 06:00 hr. Animals exit the study upon death. All animal procedures were approved by the Animal Care and Use Committee at The Jackson Laboratory.

From enrollment until 6 months of age, all mice were on an AL diet of standard rodent chow 5KOG from LabDiet. At 6 months of age, each cage of eight animals was randomly assigned to one of five dietary treatments, with each cohort equally split between the five groups (N = 192/group): AL, 20% CR (20), 40% CR (40), 1 day per week fast (1D), and 2 days per week fast (2D) (see Figure 1A). In a previous internal study at the Jackson Laboratory, the average food consumption of female DO mice was estimated to be 3.43 g/day. Based on this observation, mice on 20% CR diet were given 2.75 g/mouse/day and those on 40% CR diet were given 2.06 g/mouse/day. Food was weighed out for an entire cage of eight. Observation of the animals indicated that the distribution of food consumed was roughly equal among all mice in a cage across diet groups.

Mice on AL diet had unlimited food access; they were fed when the cage was changed once a week. In rare instances when the AL mice consumed all food before the end of the week, the grain was topped off midweek. Mice on 20% and 40% CR diets were fed daily. We gave them a triple feeding on Friday afternoon to last till Monday afternoon. As the number of these mice in each cage decreased over time, the amount of food given to each cage was adjusted to reflect the number of mice in that cage. Fasting was imposed weekly from Wednesday noon to Thursday noon for mice on 1D diet and Wednesday noon to Friday noon for mice on 2D diet. Mice on 1D and 2D diets have unlimited food access (similar to AL mice) on their nonfasting days.

From enrollment until 660 days of age, each animal underwent a number of phenotypic assays to assess a wide range of physiological health parameters. These included two 7-day stints in Sable Systems Promethion metabolic cages at 120 and 390 days of age, two blood draws at 160 and 480 days of age, and one of each of the following challenge-based assays at 300–330 days of age: 3-day stint in a cage with wheel, rotarod, grip strength, dual-energy X-ray absorptiometry, echocardiogram, Y-maze spontaneous alternation, and acoustic startle.

Body weight measurements

Body weight was measured once every week for each mouse throughout its life. The body weight measurements for this analysis were collated on February 1, 2020, at which point 941 mice (98%) had measurements at 180 days, 890 (93%) at 365 days, 813 (85%) at 550 days, and 719 (75%) at 660 days. For these analyses, we included all body weight measures for each mouse up to 660 days of age. We smoothed out measurement noise, either due to errors in measurement or swaps in assigning measurements to mice, using an 1 trend filtering algorithm (Kim et al., 2009), which calculates a piecewise linear trend line for body weight for each mouse over its measurement span. The degree of smoothing was learned by minimizing the error between the predicted fit and measurements at randomly held-out ages across all mice. In the rest of this article, body weight and growth rate refer to the predicted fits from 1 trend filtering.

We present the average trends in body weight and growth rate, stratified by dietary intervention, in Figure 1B and C, respectively. The body weight and growth rate trends without 1 trend filtering are presented in Figure 1—figure supplement 1. The most prominent observation from these trends is that dietary intervention contributes the most to variation in body weight in this mouse population. After accounting for this source of variation, there remain substantial and different quantities of variation in body weight trends within the different dietary interventions, suggesting the existence of heteroscedastic noise or plausible G×D interaction effects on body weight trajectories.

Genotype measurements

We collected tail clippings and extracted DNA from 954 animals (http://agingmice.jax.org/protocols). Samples were genotyped using the 143,259-probe GigaMUGA array from the Illumina Infinium II platform (Morgan et al., 2015) by NeoGen Corp. (genomics.neogen.com/). We evaluated genotype quality using the R package: qtl2 (Broman et al., 2019). We processed all raw genotype data with a corrected physical map of the GigaMUGA array probes (https://kbroman.org/MUGAarrays/muga_annotations.html). After filtering genetic markers for uniquely mapped probes, genotype quality, and a 20% genotype missingness threshold, our dataset contained 110,807 markers.

We next examined the genotype quality of individual animals. We found seven pairs of animals with identical genotypes, which suggested that one of each pair was mislabeled. We identified and removed a single mislabeled animal per pair by referencing the genetic data against coat color. Next, we removed a single sample with missingness in excess of 20%. The final quality assurance analysis found that all samples exhibited high consistency between tightly linked markers: log odds ratio error scores were less than 2.0 for all samples (Lincoln and Lander, 1992). The final set of genetic data consisted of 946 mice.

For each mouse, starting with its genotypes at the 110,807 markers and the genotypes of the 8 founder strains at the same markers, we inferred the founders-of-origin for each of the alleles at each marker using the R package: qtl2 (Broman et al., 2019). This allowed us to test directly for association between founder-of-origin and phenotype (rather than allele dosage and phenotype, as is commonly done in QTL mapping) at all genotyped markers. Using the founder-of-origin of consecutive typed markers and the genotypes of untyped variants in the founder strains, we then imputed the genotypes of all untyped variants (34.5 million) in all 946 mice. Targeted association testing at imputed variants allowed us to fine-map QTLs to a resolution of 1–10 genes.

Motivating models for environment-dependent genetic architecture

Genome-wide QTL analyses in model organisms over the last decade have predominantly employed linear mixed models (e.g., EMMA Kang et al., 2008), FastLMM [Lippert et al., 2011], GREML [Yang et al., 2011], GEMMA [Zhou and Stephens, 2012], and LDSC [Bulik-Sullivan et al., 2015], expanding on the heuristic that samples sharing more of their genome have more correlated phenotypes than genetically independent samples. We found that the distributions of covariances in body weight, measured at 500 days of age, between animal pairs within the AL treatment were nearly indistinguishable when we partition pairs into high-kinship (>0.2) and low-kinship groups (Figure 2, no significant separation between solid and dashed red lines). However, animal pairs in the 40% CR treatment exhibited significantly lower covariance in body weight in the low-kinship group compared to the high-kinship group (Figure 2, significant separation between solid and dashed orange lines). This observation suggests that the genetic contribution to body weight is different in distinct dietary environments. This observation also motivates the use of recently developed generalized linear mixed models to conduct genome-wide QTL analysis because they more fully account for environment-dependent genetic variances, reduce false-positive rates, and increase statistical power (Yang et al., 2011; Sul et al., 2016; Runcie and Crawford, 2019; Moore et al., 2019; Dahl et al., 2020).

Figure 2. Illustrating diet-dependent association between genetic and phenotypic similarities.

Figure 2.

Phenotypic divergence between animal pairs is quantified by the covariance in body weight at 500 days of age. We plot the cumulative density of body weight covariance for all pairs of animals in the ad libitum (AL) and 40% calorie restriction (CR) dietary treatments, partitioned into high-kinship (>0.2) or low-kinship groups. We test for separability between the high- and low-kinship distributions using the Mann–Whitney U test, and report p-values from this test. The reported area under the curve (AUC) is a standard transformation of the Mann-Whitney U test statistic.

Simulations

To evaluate the accuracy of G×EMM and compare it against standard linear mixed models like EMMA (Kang et al., 2008), we simulated phenotypic variation under a broad range of values for proportion of phenotypic variance explained by genetics (PVE) in each of two environments. For all simulations, we fixed the total sample size to N=946 and used the observed kinship matrix for the 946 DO mice in this study. For these simulations, the environment-specific genetic contribution PVEe, environment-specific noise σe2, and the relative distribution of samples between environments are the tunable parameters. In order to explore how the two models behaved under a wide range of conditions, we varied PVEe{0.05,0.10,,0.95}, fixed σe12=σe22=1.0, and assigned samples to environments either at a 1:1 ratio or a 4:1 ratio (i.e., a total of 114 parameter values). For each setting of the tunable parameter values, we ran 50 replicate simulations and in each simulation, we randomly assigned samples to one of the two environments. Given the environment assignments, kinship matrix, and the set of tunable parameter values for each simulation, we computed the environment-specific genetic variance using Equation 13, Equation 14, and Equation 15. Next, we generated the vector of phenotypes from a multivariate normal distribution with zero mean and covariance structure dependent upon the observed kinship matrix, environment assignments, tunable parameter settings, and the environment-specific genetic variance for each environment. Using the simulated phenotypes, we computed estimates of PVEtot under both the EMMA and G×EMM models and estimates of PVEe under the G×EMM model.

We first evaluated the accuracy of PVEtot estimated from the two models and found that the G×EMM model estimated total PVE with little bias and lower variance compared to EMMA in nearly all simulations across the suite of parameter combinations that we investigated (Figure 3A and B). In particular, we found that EMMA substantially underestimated the total PVE in comparison to G×EMM when samples were equally distributed between environments and there was substantial difference in PVE or noise between environments. This is because PVEe will have a greater impact on PVEtot when both environments are more equally represented in the study sample.

Figure 3. Evaluating gene–environment mixed mode (G×EMM) and EMMA using simulated datasets.

Figure 3.

(A). Comparison of true PVEtot to that estimated from EMMA (left panel) and G×EMM (right panel). Simulations were run with an equal number of samples in each environment (Ne1=Ne2) and with the same value for the environment-specific error terms (σe12=σe22=1). (B). Same as (A) but with a 4:1 ratio of samples between environments (Ne1=4×Ne2). (C). Plot of the true PVEe2 vs. the G×EMM estimate of PVEe2. Gray points are the results of individual simulations, orange lines denote the median and 95% interquartile range (IQR). The three panels differ in the true proportion of phenotypic variance explained by genetics (PVE) specific to environment 1, PVEe1{0.2,0.5,0.8}. Simulations were run with an equal number of samples in each environment (Ne1=Ne2) and with the same value for the environment-specific error terms (σe12=σe22=1). (D). Same as (C) but with a 4:1 ratio of samples between environments (Ne1=4×Ne2).

Next, we examined the sensitivity and specificity of the G×EMM model to quantify environment-specific genetic contribution to phenotypic variance. We found that when samples were equally distributed between environments, G×EMM accurately estimates PVEe under a wide range of parameter values (Figure 3C). When there was a skew in the number of samples between environments, the PVEe estimate for the environment with the larger sample size was as accurate as when there was no skew in sample size (similar to Figure 3C, result not shown). In contrast, the PVEe estimate for the environment with the smaller sample size was more variable and the median PVEe estimates were consistently lower than the true PVEe (Figure 3D). Finally, we observed that increasing the environment-specific noise terms, σe12 and σe22, increased the variance of our estimates of PVEe but introduced little bias (results not shown).

Overall, the G×EMM model outperforms the EMMA model in estimating total PVE and shows little bias in estimating environment-specific PVE across a broad range of scenarios relevant to our study.

Overview of analyses

Starting with body weight measurements in 959 mice from 30 to 660 days of age, and founder-of-origin alleles inferred at 110,807 markers in 946 mice, we first quantified how the heritability of body weight and growth rate changes with age and between dietary contexts. We used the G×EMM model (described in detail in ‘Materials and methods’) to account for both additive environment-dependent fixed effects and polygenic gene–environment interactions. We considered two different types of environments: diet and generation. The five diet groups were applied from 180 to 660 days and the 12 generations were applied from 30 to 660 days. Next, we performed genome-wide QTL mapping for body weight at each age independently, testing for association between body weight and the inferred founder-of-origin at each genotyped marker. For ages 180–660 days, we additionally tested for association between body weight and the interaction of diet and founder-of-origin at each marker. We computed p-values using a sequential permutation procedure (Besag and Clifford, 1991; Shim and Stephens, 2015) at each variant for each of the additive and interaction tests and used these to assign significance (Abney, 2015). Finally, for each significant locus, we performed fine-mapping to identify the putative causal variants and founder alleles driving body weight and underlying functional elements (genes and regulatory elements) to ascertain the possible mechanisms by which these variants act.

PVE of body weight across age and diet

First, we quantified the overall contribution of genetics to variation in body weight and, importantly, how this contribution changed with age. We applied both EMMA and G×EMM to body weight estimated every 10 days. Since the mice from each generation cohort were measured at the same time every week, we used generation as a proxy for the shared environment that mice are exposed to as part of the study design. We accounted for generation-specific fixed effects (α in Equation 1) in both models and genotype-generation random effects (γ) in G×EMM. For ages after dietary intervention (180 days), we additionally accounted for diet-specific fixed effects in both models and genotype-diet random effects in G×EMM. We estimated the variance components in the model at each age independently and computed the total and diet-dependent PVE using Equation 7 and Equation 13.

In Figure 4A, we observed that the PVE of body weight steadily increased during early adulthood and up to 180 days of age, when dietary intervention was imposed. The G×EMM model estimates a higher PVE than the EMMA model during this age interval because the former model specifically accounts for polygenic genotype-generation effects. Following dietary intervention, PVE decreased in four of the five dietary groups; the one exception was the 40% CR group, which maintained a high PVE (PVE400.8) (Figure 4A) and low total phenotypic variance (Figure 4—figure supplement 3A, top-right panel) from 180 to 660 days of age. In contrast, the AL group had the lowest PVE and greatest total phenotypic variance in the same age range. Notably, 1 trend filtering of the raw measurements proved useful in quantifying smoothly varying trends in the PVE of body weight and growth rate, and improving our estimates of the PVE of growth rate by reducing the effect of measurement noise (Figure 4—figure supplement 1). Moreover, these results were robust to variation in the genetic data used to calculate the kinship matrix and to survival bias at 660 days of age.

Figure 4. Proportion of phenotypic variance explained by genetics.

(A) Body weight proportion of phenotypic variance explained by genetics (PVE) (± SE) for 30–660 days of age. Total PVE estimates are derived from the EMMA (light gray) and gene–environment mixed mode (G×EMM) (dark gray) models. Diet-dependent PVE values were derived from the G×EMM model. Dotted vertical line at 180 days depicts the time at which all animals were switched to their assigned diets. (B) Growth rate PVE; details the same as (A).

Figure 4.

Figure 4—figure supplement 1. Proportion of phenotypic variance explained by genetics (PVE) using raw measurements.

Figure 4—figure supplement 1.

PVE (±SE) of (A) Body weight and (B) growth rate, estimated using raw body weight measurements.
Figure 4—figure supplement 2. Proportion of phenotypic variance explained by genetics (PVE) overlayed with phenotyping.

Figure 4—figure supplement 2.

PVE (± SE) of (A) Body weight and (B) growth rate, overlayed with the timing of bouts of phenotyping.
Figure 4—figure supplement 3. Sensitivity of proportion of phenotypic variance explained by genetics (PVE).

Figure 4—figure supplement 3.

(A) PVE (± SE) (left column) and expected phenotypic variance (±SE) (right column) estimated using kinship calculated from founder-of-origin allele probabilities (top row) and biallelic genotypes (bottom row). (B) PVE (±SE) estimated using kinship calculated from founder-of-origin allele probabilities (left column) and biallelic genotypes (right column), after randomly permuting body weight trajectories across mice, within each dietary intervention. (C) PVE (±SE) estimated using all mice in the study (left column) and mice that survived to 660 days of age (right column).
Figure 4—figure supplement 4. Proportion of phenotypic variance explained by genetics (PVE) with no constraints on variance components.

Figure 4—figure supplement 4.

PVE (±SE) of body weight was estimated without imposing any non-negativity constraints on the variance components in the gene–environment mixed mode (G×EMM) model.
Figure 4—figure supplement 5. Proportion of phenotypic variance explained by genetics (PVE) comparing full and diagonal Ω.

Figure 4—figure supplement 5.

PVE (± SE) of body weight was estimated with and without a diagonal constraint on Ω.
Figure 4—figure supplement 6. Proportion of phenotypic variance explained by genetics (PVE) decomposition.

Figure 4—figure supplement 6.

Decomposing the total and diet-dependent PVE into contributions from diet terms (diamonds) and contributions from generation terms (x-markers).

The kinship matrix used for estimating these PVE values was computed based on the founder-of-origin of marker variants (Aylor et al., 2011). When using kinship estimated using biallelic marker genotypes (as is commonly done in genome-wide association studies [GWAS]), we observed largely similar trends in PVE; however, differences in PVE between diets after 400 days were harder to discern due to much larger standard errors for the estimates (Figure 4—figure supplement 3A, left panels). To test for bias or calibration errors in our PVE estimates, we randomly permuted the body weight trends between mice in the same diet group and recalculated the total and diet-dependent PVE values. Consistent with our expectations, PVE dropped to nearly zero for the permuted dataset (Figure 4—figure supplement 3B, left panel), indicating that the PVE estimates are well-calibrated. Finally, to evaluate the contribution of survival bias to our estimates, we recomputed PVE at all ages after restricting the dataset to mice that were alive at 660 days. We observed PVE estimates largely similar to those computed from the full dataset, suggesting very little contribution of survival bias to our estimates (Figure 4—figure supplement 3C).

When using kinship computed from genotypes, we note that the PVE in the permuted dataset does not drop to zero, suggesting that genotype-based kinship includes some background relatedness that can explain some of the phenotypic variation even after permuting the labels (Figure 4—figure supplement 3B, right panel). The genotype-based kinship includes two components: the genetic sharing between the founder strains and the genetic sharing arising from the breeding strategy used to develop the DO panel. Randomly permuting the phenotype labels breaks the link between phenotypic similarity and the latter component of genotype-based kinship, but does not effectively break the link with the former component. Kinship computed using the founder allele probabilities explicitly includes only the latter component; this component explains little phenotypic variation once the phenotype labels are randomly permuted.

Next, we quantified the age-dependent contribution of genetics to variation in growth rate, enabled by the dense temporal measurement of body weight. As before, we applied EMMA and G×EMM to growth rate estimated every 10 days. In Figure 4B, we observed that PVE of growth rate increases rapidly during early adulthood, and then decreases to negligible values around 240 days of age. In contrast to body weight, PVE of growth rate is substantially lower at all ages, and there is little divergence in PVE across diet groups for most ages. Notably, the decrease and subsequent increase in growth rate PVE coincide with specific metabolic, hematological, and physiological phenotyping procedures that these mice underwent at specific ages as part of the study (Figure 1—figure supplement 1). Due to lower values and greater variance in PVE of growth rate with age, we focus on body weight throughout the rest of the article.

In summary, the 40% CR intervention produced the greatest reduction in average body weight and maintained a high PVE after dietary intervention. This is because the genetic variance in body weight remained relatively high and the environmental variance remained relatively low throughout this interval. In contrast, body weight PVE steadily decreased with age in each of the four less restrictive diets, which was due to a steady increase in noise (nongenetic variance) and not a decrease in the genetic variance of body weight (Figure 4—figure supplement 3A). Even though the genetic variance in body weight is nearly constant across diets from 180 to 660 days of age, the effect of specific variants may change with age.

Genome-wide QTL analysis of body weight across age and diet

We sought to identify loci significantly associated with body weight in a diet-dependent and age-dependent manner. To this end, we tested for association between the inferred founder-of-origin of each typed variant and body weight at each age independently. We note that body weight measurements taken at different ages are not independent; that is, we may detect a locus at a specific age if it has small effects on body weight acting over a long period of time or a large effect on body weight, resulting in rapid bursts in growth. Thus, a locus identified as significant at a specific age indicates its cumulative contribution to body weight at that age.

We identified 29 loci significantly associated with body weight at any age in the additive or interaction models using a genome-wide Bonferroni-corrected p104 threshold for both the additive and the genotype–diet interaction tests (Figure 5—figure supplement 1). Additionally, we report suggestive genotype–diet interaction QTLs using a weaker threshold of p103. The Bonferroni correction was computed based on the expected number of linkage-disequilibrium (LD) blocks in our dataset; as a proxy for the number of LD blocks, we used the number of top eigenvalues of the LD matrix between genotyped variants that explained at least 90% of the variance across markers. This threshold also corresponds to a 10% variant-level expected false discovery rate, using the Benjamini–Hochberg method (Benjamini and Hochberg, 1995). In order to focus on highly significant associations, we also used the number of eigenvalues explaining 99.5% of the variance across markers (Gao et al., 2010), resulting in a more stringent threshold of p1.1×105 (see Table 1). Notably, these thresholds hold for the interaction tests as well because we have only one test per marker. Using all biallelic variants imputed from the complete genome sequences of the eight DO founder strains (Keane et al., 2011), we retested the genetic association for the 29 candidate loci with the additive and interaction models. Specifically, we tested for association between all imputed genotype variants and body weight, accounting for kinship estimated using founder-of-origin inferred at genotyped variants as before (see file “emma_vs_gxemm.xlsx” in Data Release: Results for a comparison of the number of significant loci with those obtained using the EMMA model).

Table 1. Candidate diet-independent and diet-dependent body weight loci.

For each locus, we identified the variant with the lowest p-value at any age, the founder allele pattern (FAP) of this variant, the number of significant variants that comprise this lead FAP, the genomic positions spanning these significant FAP variants, and all ages for which at least one FAP variant is associated with body weight. For loci in which the lead FAP is comprised of fewer than 10 significant variants, we also present results for the second FAP. We list candidate genes for loci where the FAP spans three or fewer genes. Highly significant associations (p1.1×105) are denoted with ***, significant associations (p104) with **, and suggestive associations (p103) with *.

FAP position (Mb) Significant variants Significant age range (days) Age-dependent nonlinearity Lead candidate genes (if ≤3)
Chrm Founder Allele Pattern (FAP) FAP rank p-Value Start End Total Open chromatin
Diet-independent
1 AJ/NOD 1 3.24E-05 ** 152.046626 152.046626 1 1 60 1.44E-05 Trmt1l, Edem3
AJ/NOD/129 2 3.05E-05 ** 151.473677 152.280212 58 10 60
2 129/CAST/PWK 1 2.17E-05 ** 77.154962 77.357295 80 8 120–360 2.83E-09 Ccdc141, Sestd1
3 AJ/NOD/NZO/CAST 1 1.89E-05 ** 50.533599 50.595073 55 200–260 5.03E-12 Slc7a11
4 AJ 1 6.81E-06 *** 58.950364 60.267128 5 2 260–360 3.82E-19 Ugcg
PWK/WSB 2 2.80E-05 ** 59.461248 59.981846 39 3 100–300
6 AJ/NOD 1 2.75E-07 *** 53.61761 55.555977 89 2 60–200 1.55E-26 Creb5
7 B6/CAST 1 4.20E-06 *** 71.375007 72.786849 47 1 80–160 2.48E-11 Mctp2
7 AJ/129/NZO/PWK 1 5.70E-06 *** 134.08785 134.704465 20 2 80–200 9.17E-10 Adam12
10 129/NZO/PWK/WSB 1 4.99E-06 *** 9.078054 9.078054 1 540–660 9.52E-06 Samd5
129/NZO/WSB 2 2.25E-05 ** 8.903387 9.092694 10 2 540 Sash1, Samd5
10 CAST/PWK 1 5.98E-06 *** 91.163191 91.905287 2,779 81 120–660 4.09E-10 Anks1b, Apaf1
11 AJ/NZO/PWK/CAST 1 5.89E-05 ** 58.155424 58.155424 1 80 2.35E-05
B6/CAST 2 4.91E-05 ** 56.985645 59.035309 603 70 80–100
12 NZO/CAST 1 6.47E-05 ** 99.520559 99.907182 43 3 160–260 3.83E-12 Foxn3
15 B6/129/NZO 1 4.77E-07 *** 99.390603 99.65295 92 20 260–600 1.50E-13 Aqp2, Aqp5, Aqp6
17 AJ/NOD/WSB 1 8.56E-06 *** 6.753277 8.85311 149 11 60–420 1.23E-10 Pde10a
19 AJ/129/NZO/PWK 1 7.90E-05 ** 23.025043 23.17612 58 14 80–120 4.46E-09 Trpm3, Klf9
Diet-dependent
1 NOD/CAST 1 4.89E-04 * 151.032114 153.716837 28 3 360–660 3.32E-04
2 AJ/CAST/PWK/WSB 1 7.74E-04 * 22.192222 22.78664 86 8 480 1.32E-04
2 PWK 1 3.34E-04 * 73.590142 75.371564 1,672 44 280–300 4.62E-03
3 NOD/CAST/PWK/WSB 1 3.87E-05 ** 50.184746 50.419821 5 420–660 7.90E-04 Slc7a11
3 B6/PWK 1 8.29E-05 ** 156.74554 156.74554 1 660 1.60E-05 Negr1
129/CAST/WSB 2 7.33E-04 * 156.133466 156.387825 170 8 660
4 129/NOD/PWK 1 9.61E-04 * 57.696301 57.84652 10 1 200 5.10E-07 Palm2, Pakap, Akap2
NOD 2 9.76E-04 * 57.669827 57.669827 1 200
5 NOD 1 3.88E-05 ** 19.213904 21.57007 153 16 420–660 2.26E-03 Magi2, Ptpn12
5 PWK 1 5.84E-04 * 68.986655 70.490341 277 360–480 2.28E-03 Kctd8
5 AJ/129/NOD/WSB 1 4.00E-05 ** 117.543498 118.050453 7 480–540 1.55E-03
B6/CAST/PWK 2 1.04E-04 * 116.797769 118.270745 69 10 360–600
6 B6/CAST/PWK 1 1.04E-04 * 54.146132 55.452827 507 101 540–660 7.51E-04 Ghrhr
6 B6/CAST 1 1.68E-05 ** 139.190506 140.141694 111 5 240–420 9.63E-03 Pik3c2g
7 NZO/PWK 1 9.60E-04 * 133.838117 133.924023 218 3 420 3.19E-07 Adam12
12 AJ/B6 1 6.29E-04 * 78.06102 79.734912 10 2 420–540 4.23E-04 Gphn
WSB 2 9.84E-04 * 78.107988 78.932842 122 8 360–420 Gphn
12 AJ/CAST/PWK/WSB 1 3.53E-04 * 102.447268 102.56532 43 4 420–480 2.59E-05
13 NZO/WSB 1 1.00E-04 ** 117.100864 118.777463 99 1 200–300 1.14E-03 Fgf10
15 AJ/129/NOD 1 3.52E-04 * 10.738034 12.040137 53 4 240–300 1.27E-04
17 B6/129/NZO 1 7.52E-04 * 6.755865 7.598818 26 3 300–360 3.23E-03
18 129/CAST 1 3.86E-04 * 71.36087 71.58844 16 1 480–540 6.92E-03 Dcc
19 AJ/B6/WSB 1 1.24E-04 * 21.806665 22.051277 32 1 220–300 3.54E-03

Our fine-mapping analysis confirmed 24 candidate loci: 5 loci unique to the additive model, 10 loci unique to the interaction model, and 9 loci significant in both models (Table 1). We identified body weight associations with age-dependent effects from early adulthood to adulthood: four diet-independent loci were associated with body weight exclusively during early adulthood (ages 60–160 days) and three were associated exclusively during adulthood (ages 200–660 days); the remaining seven loci were associated prior to the imposition of dietary restriction at day 180 and continued to be associated into adulthood (Table 1). The majority of diet-dependent loci (12 of 19) had a detectable effect on body weight at least 240 days after dietary intervention (ages 420–660 days; Table 1). For each candidate body weight locus, we sought to determine the likely set of causal variants and estimate the effect of the eight founder alleles in a diet- and age-dependent manner.

Improved mapping resolution with founder allele patterns

In order to facilitate characterization and interpretation of the genetic associations at each locus, we sought to represent these associations in terms of the effects of founder haplotypes (Zhang et al., 2022). First, we determined the founder-of-origin for each allele at every variant that was significant in at least one age. This allowed us to assign a founder allele pattern (FAP) to each significant variant in the locus. For example, if a variant with alleles A/G had allele A in founders AJ, NZO, and PWK and the allele G in the other five founders, then we assign A to be the minor allele of this variant and define the FAP of the variant to be AJ/NZO/PWK. Next, we grouped variants based on FAP and define the logarithm of the odds (LOD) score of the FAP group to be the largest LOD score among its constituent variants. (Note that, by definition, no variant can be a member of more than one FAP group.) By focusing on the FAP groups with the largest LOD scores, we significantly reduced the number of putative causal variants (Table 1, see file all_significant_snps.csv in Data Release: Results), while representing the age- and diet-dependent effects of these loci in terms of the effects of its top FAP groups. We further narrowed the number of candidates by intersecting the variants in top FAP groups with functional annotations (e.g., gene annotations, regulatory elements, tissue-specific regulatory activity, etc.). For many loci, this procedure identified candidate regions containing 1–3 genes (Table 1), and we provide the full list of all genes within candidate regions in the file all_significant_genes.csv in Data Release: Results. In order to demonstrate the utility of this approach, we first examined a single locus on chromosome 6 strongly associated under the additive model.

We used this approach to examine a diet-independent locus on chromosome 6 significantly associated with body weight during early adulthood (Figure 5A). Interestingly, this same locus was nominally associated with body weight in certain dietary treatments at later ages. We hypothesized that the functional variant(s) responsible for the diet-dependent body weight association at this locus are among the variants in the respective lead FAP groups because they exhibit the strongest statistical association and it is unlikely any additional variants are segregating in this genomic interval beyond those identified in the full genome sequences of the eight founder strains. For the diet-independent locus, at age 120, we identified 87 significantly associated variants; of these, 79 could be assigned to the lead FAP group and shared a similarly high LOD score (Figure 5B). All of these variants are single-nucleotide polymorphisms (SNPs located in the gene Creb5, 78 are intronic and 1 a synonymous exon variant). For the diet-dependent locus, at age 600 days, we identified 617 variants as significant; of these, 507 could be assigned to the lead FAP and shared a similarly high LOD score (Figure 5D). Also, 2 of the 507 variants were intergenic structural variants; of the remaining SNPs, 5 were noncoding exon variants, 167 were intronic, and the remainder were intergenic. Given that all candidate variants were noncoding, we next sought to determine whether they were located in regulatory elements across a number of tissues, identified as regions of open chromatin measured using ATAC-seq (Cusanovich et al., 2018) or DNase-seq (Gorkin et al., 2020) (see file "chromatin_accessibility_celltypes.xlsx" in Data Release: Results for a description of the cell types for each of the assays, and their grouping into tissues). For the diet-independent and diet-dependent loci, we found 2 and 101 variants, respectively, that were located in regions of open chromatin (Figure 5C and E). Notably, both variants with diet-independent effects lay within the same muscle-specific regulatory element located within Creb5, suggesting that these variants likely affected body weight by regulating gene expression in muscle cells.

Figure 5. Distinct founder allele patterns (FAPs) contribute to diet-independent and diet-dependent effects on body weight within a region on chromosome 6.

(A) Manhattan plots of additive genetic associations and genotype–diet associations on chromosome 6 at multiple ages. (B, D) Fine-mapping loci associated with body weight: diet-independent association at 120 days of age and diet-dependent association at 600 days of age. Solid circles indicate significant variants. Colors denote variants with shared FAPs; ranks 1, 2, and 3 by logarithm of the odds (LOD) score are colored red, orange, and yellow, respectively. (C, E) Significant variants, colored by their FAP group, along with the gene models (shown in blue) and the tissue-specific activity of regulatory elements near these variants (shown in gray). Significant variants that lie within regulatory elements are highlighted as diamonds, and regulatory elements that contain a significant variant are highlighted in black.

Figure 5.

Figure 5—figure supplement 1. Age- and diet-dependent Manhattan plots for body weight, with gene–environment mixed mode (G×EMM).

Figure 5—figure supplement 1.

Genetic loci associated with body weight, using G×EMM, at different ages identified under the additive genetic model (subpanels on the left) and genotype–diet interaction model (subpanels on the right). Each circle is a genotyped marker, significant markers are in red.
Figure 5—figure supplement 2. Age- and diet-dependent Manhattan plots for body weight, with EMMA.

Figure 5—figure supplement 2.

Genetic loci associated with body weight, using EMMA, at different ages identified under the additive genetic model (subpanels on the left) and genotype–diet interaction model (subpanels on the right). Each circle is a genotyped marker, significant markers are in red.
Figure 5—figure supplement 3. Loci with significant diet-independent and diet-dependent associations with body weight.

Figure 5—figure supplement 3.

(A) Fine-mapping a locus on chromosome 1 associated with body weight under the additive model (left column) and genotype–diet interaction model (right column). Each circle is a biallelic variant, both imputed and genotyped, and solid circles denote significantly associated variants. Variants are colored according to their founder allele pattern (FAP); FAPs of ranks 1, 2, and 3 (based on logarithm of the odds [LOD] score) are colored red, orange, and yellow, respectively. Panels (BF) are the same as (A) for loci on chromosomes 2, 4, 12, 17, and 19.
Figure 5—figure supplement 4. Distinct founder allele patterns (FAPs) drive diet-independent and diet-dependent associations with body weight at various loci.

Figure 5—figure supplement 4.

(A) Fine-mapping a locus on chromosome 3 associated with body weight under the additive model (left column) and genotype–diet interaction model (right column). Each circle is a biallelic variant, both imputed and genotyped, and solid circles denote significantly associated variants. Variants are colored according to their FAP; FAP with ranks 1, 2, and 3 are colored red, orange, and yellow, respectively. (B) Founder allele effect as a function of age for the lead FAP variant from (A) for the diet-independent association (left column) and the diet-dependent association (right column). Panels (C) and (D) are the same as (A) and (B) for a locus on chromosome 7.

Next, we identified a locus on chromosome 12 with strong diet-dependent effects on body weight from 300 to 420 days of age (Table 1; Figure 6). Upon fine-mapping the locus with the strongest association, at 420 days of age, we identified 77 significant variants partitioning into two distinct lead FAP groups, with similarly high LOD scores and centered at the same gene (Figure 6A and B). The rank 1 FAP group contained variants with the minor allele specific to AJ and B6, whereas the rank 2 FAP group contained variants with the minor allele specific to WSB (Figure 6A). We found that the minor allele of the lead imputed variant in the AJ/B6 FAP group was associated with increased body weight in the 2D fasting diet, but had little effect on the other four diets (Figure 6C). In contrast, the minor allele of the lead imputed variant from the WSB-specific FAP group had the largest positive effect on body weight in the AL and 1D fast diet and largest negative effect on body weight in the 40% CR diet (Figure 6C). The striking difference in diet-specific effects for WSB and AJ/B6 alleles suggests that there are multiple functional variants affecting body weight at this locus (e.g., allelic heterogeneity; Singh, 2013). Of the 77 variants, the AJ/B6 FAP group contained six intergenic SNPs and four intronic SNPs spanning three genes: Gphn (gephyrin), Plekhh1, and Rad51b (Figure 6A). One of these 10 variants is located in a regulatory element active specifically in adipose tissue. The remaining 67 significant variants all belonged to the WSB-specific FAP group; of these, 23 SNPs were intergenic and 44 were intronic and centered at the gephyrin gene. Also, 4 of these 67 variants were located in regulatory elements active in adipose tissue as well as other tissues relevant to metabolism (Figure 6D).

Figure 6. Multiple founder allele patterns (FAPs) at a body weight QTL on chromosome 12 show distinct diet-dependent effects.

Figure 6.

(A) Fine-mapping loci, under the interaction model, at 420 days of age. Significant variants are marked as solid circles. Colors denote variants with shared FAPs; ranks 1, 2, and 3 by logarithm of the odds (LOD) score are colored red, orange, and yellow, respectively. (B) Log odds ratio as a function of age, for a single variant that exhibits the strongest association from each of the top three FAPs. (C) Age and diet-dependent effect size of variants with the strongest associations specific to either the WSB minor allele or AJ/B6 minor allele. (D) Significant variants, colored by their FAP, along with the gene models (shown in blue) and the tissue-specific activity of regulatory elements near these variants (shown in gray). Significant variants that lie within regulatory elements are highlighted as diamonds and regulatory elements that contain a significant variant are highlighted in black.

No evidence for pleiotropic alleles affecting diet-independent and dependent effects

We identified a diet-independent locus on chromosome 6 significantly associated with body weight during early adulthood and nominally associated with body weight in certain dietary treatments at later ages (Figure 5A). One explanation for this result is a single pleiotropic allele affecting body weight at two distinct stages of life: early adulthood and mid-late adulthood. Alternatively, this result could be explained by multiple alleles at a single locus (perhaps similar to the allelic heterogeneity observed in Figure 6) or multiple loci in tight LD. Fine-mapping this locus using the additive model, we identified the variant with the highest LOD score to be at 53.6 Mb. The minor allele at this lead variant was common to the AJ and NOD founders, while the remaining six founders possessed the alternate allele; this defined the lead diet-independent FAP at this locus to be AJ/NOD (Figure 5B). Separately, we fine-mapped this locus using the interaction model, identified the lead variant at 55.1 Mb, and determined the lead FAP to be B6/CAST/PWK (Figure 5D). These results do not support the pleiotropy hypothesis and were consistent with the hypothesis that distinct body weight alleles derived from different DO founders were responsible for the diet-dependent and diet-independent body weight associations.

We next fine-mapped other QTLs that had diet-dependent and diet-independent associations located in adjacent genomic regions to assess whether the associations were due to a single pleiotropic allele or, as we found on chromosome 6 (Figure 5B and D), the additive and interaction effects were due to distinct alleles. Of the eight additional diet-dependent and diet-independent associations that colocalized to the same genomic region (Table 1), all of them were consistent with the hypothesis that distinct FAPs rather than a single pleiotropic allele were responsible for diet-dependent and diet-independent associations. The first six loci were located in adjacent genomic regions (Figure 5—figure supplement 3). The remaining two loci were composed of similar (although, not identical) FAP groups located in overlapping genomic regions (Figure 5—figure supplement 4). At one of these loci, on chromosome 3, the FAP driving the diet-dependent association was NOD/CAST/PWK/WSB, whereas the diet-independent association was due to AJ/NOD/NZO/CAST (Figure 5—figure supplement 4A). The diet-dependent and diet-independent chromosome 7 loci are due to differential effects between NZO/PWK and AJ/129/NZO/PWK, respectively (Figure 5—figure supplement 2D). In summary, we identified multiple instances of diet-dependent and diet-independent associations that mapped to the same genomic region and for all of these loci we determined that distinct FAPs were responsible for diet-dependent or diet-independent effects on body weight.

Nonlinear changes in genetic effects with age

We found that the relationship between model LOD score and age was similar for each of the three lead FAPs at the diet-independent and diet-dependent loci on chromosome 6 (Figure 7A and B). The minor allele of the lead variant at the diet-independent locus was associated with increased body weight at young ages (Figure 7C), whereas the minor allele for the lead diet-dependent variant had a positive effect on body weight under the 20% CR diet, a nearly neutral effect under the 40% CR, and a negative effect under the AL diet (Figure 7D). We next measured the effect of each founder allele at the lead diet-independent genotyped marker and, consistent with the lead FAP group for the diet-independent association, the AJ and NOD alleles had large positive effects at young ages (Figure 7E). For the diet-dependent association, B6, CAST, and PWK alleles were associated with decreased body weight in the AL diet and increase in body weight in the 20% CR diet (Figure 7F), consistent with their role in defining the lead diet-dependent FAP group. This example clearly demonstrates the insight gained by focusing on lead FAP variants to link specific founder alleles to variation in body weight and narrow the number of potential functional variants underlying body weight.

Figure 7. Body weight loci on chromosome 6 exhibit age- and diet-specific effects.

(A) Log odds ratio of additive body weight association as a function of age for the lead variant from each founder allele pattern (FAP) group. Red, orange, and yellow colors denote lead variant for rank 1, 2, and 3 FAPs. (B) Same as (A) for interaction body weight association on chromosome 6. (C, D) Estimated mean (SE) effect on body weight (grams) of the minor allele for the lead imputed variant. For the diet-dependent locus (D), effects are shown for each diet treatment. (E) Estimated mean effect (±SE) on body weight of each founder allele for the genotyped marker with the highest logarithm of the odds (LOD) score from the additive model. (F) Estimated effect (±SE) on body weight of each founder allele under the ad libitum (AL) and 20% calorie restriction (CR) diets.

Figure 7.

Figure 7—figure supplement 1. Diet-dependent association with body weight in a locus on chromosome 5.

Figure 7—figure supplement 1.

(A) Manhattan plots of additive genetic associations and genotype–diet associations on chromosome 5 at multiple ages. (B) Fine-mapping a locus associated with body weight in diet-dependent manner at 660 days of age. Each circle is a biallelic variant, both imputed and genotyped and solid circles denote significantly associated variants. Variants are colored according to their founder allele pattern (FAP); FAPs of ranks 1, 2, and 3 (by logarithm of the odds [LOD] score) are colored red, orange, and yellow, respectively. (C) Significant variants, colored by their FAP, along with the gene models (shown in green) and the tissue-specific activity of regulatory elements near these variants (shown in gray). Significant variants that lie within regulatory elements are highlighted as diamonds, and regulatory elements that contain a significant variant are highlighted in black. (D) Log odds ratio as a function of age, for a single variant that exhibits the strongest association from each of the top three FAPs. (E) Diet-dependent effect size of the minor allele as a function of age, for the variant with the strongest association. (F) Estimated effect of each founder allele in three diets (ad libitum [AL], 20, 40), at the genotyped variant with the strongest diet-dependent association.
Figure 7—figure supplement 2. Nonlinear trends in genetic effects with respect to age and dietary intervention.

Figure 7—figure supplement 2.

For each fine-mapped locus (A-G), we note the location of the variant with the strongest association and the ages at which the genetic association is significant and plot the estimated effect (SE) of this variant as a function of age, under different diets.

Given high temporal resolution in the measurements of body weight, we tested for nonlinearity in the trends of effect size with age for all significant loci in Table 1. Specifically, for each diet-independent locus, we tested for nonlinearity in the effect size trend with age in at least one founder allele of the lead variant, and for each diet-dependent locus, we tested for nonlinearity in at least one (founder, diet) pair at the lead variant (referred to as ‘age-dependent nonlinearity’). In addition to diet-dependent nonlinearity, we also observed age-dependent nonlinearity at the diet-independent locus on chromosome 6 (Figure 7C; p=1.35×1013). Surprisingly, the nonlinearity at this locus appears to be largely driven by the AJ founder background (Figure 7E; AL, yellow trace, p=1.55×1026 vs. NOD, navy trace, p=6.5×106), indicating that the effects of different founder alleles on body weight can have substantially different trends with age. Overall, we observed age-dependent nonlinearity to be predominant, with all 14 diet-independent loci exhibiting nonlinear trends with at least one founder allele (Table 1). In contrast, we observed nonlinear trends with age for diet-dependent effects to be less common, with only 4 of 19 diet-dependent loci exhibiting nonlinear trends with age in the effects of at least one founder allele under one diet. Additionally, nonlinearity was often specific to a subset of founder strains that are driving the associations at each locus, suggesting that the genetic background plays an important role when interpreting the dynamics of the genetic architecture of body weight in DO mice. Notably, such age-dependent nonlinearity often cannot be discerned even with large cross-sectional data that are typical of modern GWAS in humans.

Nonlinear changes in diet-specific genetic effects

The diet-dependent locus on chromosome 6 illustrated a rather counterintuitive result; while we observed an approximately linear reduction in median body weight between the AL, 20% CR, and 40% CR diets in response to a linear reduction in calories (Figure 1B), the effects of this locus on body weight were nonlinear in the context of each diet (Figure 7D). We defined diet-dependent effects to have a nonlinear trend with respect to diet (referred to as ‘diet-dependent nonlinearity’) if the genetic effects in the context of either the 20% CR or 1D fast treatments deviated substantially from the average of the genetic effects in the context of AL and 40% CR diets or AL and 2D fast diets, respectively. We observed a second instance of diet-dependent nonlinearity at a locus we mapped to chromosome 5. This locus had the strongest diet-dependent association observed in the genome. The lead FAP group, containing variants with an allele private to the NOD strain, was associated with large positive effect on body weight in the 20% CR diet, a small positive effect in the 1D fast diet, and nearly neutral effects in the 40% CR, 2D fast, and AL diets (Figure 7—figure supplement 1). In total, we found this pattern to be quite common, with 9 of the 19 significant loci identified under the interaction model exhibiting diet-dependent nonlinearity (Figure 7—figure supplement 2).

Candidate body weight genes linked to neurological and metabolic processes

Of the 24 significant loci from the additive and interaction models, we identified 14 loci with lead FAP groups spanning 1–3 genes (Table 1). Many of these genes implicated in modulating body weight are also known to affect neurological and metabolic processes.

One example is the neuronal growth regulator 1 (Negr1) gene, a candidate linked to body weight in mid-late adulthood via the lead 129/CAST/WSB FAP group within a diet-dependent locus on chromosome 3. This gene is highly expressed in the cerebral cortex and hippocampus in the rat brain (Miyata et al., 2003) and is known to regulate synapse formation of hippocampal neurons and promote neurite outgrowth of cortical neurons (Hashimoto et al., 2008; Sanz et al., 2015). Negr1 has also been implicated in obesity (Lee et al., 2012), autistic behavior, memory deficits, and increased susceptibility to seizures (Singh et al., 2018) in mice, and body mass index (Speliotes et al., 2010), and major depressive disorder (Hyde et al., 2016) in humans. Another example is the gephyrin gene (Gphn) implicated by two distinct FAP groups in the diet-dependent locus on chromosome 12 (Figure 6A). Gephyrin is a key structural protein at neuronal synapses that ensures proper localization of postsynaptic inhibitory receptors. Gephyrin is also known to physically interact with mTOR and is required for mTOR signaling (Sabatini et al., 1999), suggesting two plausible pathways for influencing body weight. On chromosome 1, murine Trmt1l (Trmt1-like), a gene with sequence similarity to orthologous tRNA methyltransferases in other species, was linked to body weight during early adulthood (Figure 5—figure supplement 3A). Mice deficient in this gene, while viable, have been found to exhibit altered motor coordination and abnormal exploratory behavior (Vauti et al., 2007), suggesting that the association at this locus is possibly mediated through modulating exploratory behavior. The association of these three candidates with mouse body weight is consistent with human body mass index and obesity GWAS that found an enrichment of genes active in the central nervous system (Locke et al., 2015; Yengo et al., 2018; Schlauch et al., 2020).

Among candidates that affect metabolic processes, Creb5, a gene linked to diet-independent effects on body weight (Figure 5B), has previously been reported to be linked to metabolic phenotypes in humans, with differential DNA methylation detected between individuals with large differences in waist circumference, hypercholesterolemia, and metabolic syndrome (Salas-Pérez et al., 2019). Another gene important for metabolic control in the liver, Pik3c2g was linked to diet-dependent effects on body weight in mid-adulthood. Pik3c2g-deficient mice are known to exhibit reduced liver accumulation of glycogen and develop hyperlipidemia, adiposity, and insulin resistance with age (Braccini et al., 2015). Edem3, another candidate gene at the locus on chromosome 1 linked to body weight in early adulthood (Figure 5—figure supplement 3A), has previously been linked to short stature in humans based on family-based exome sequencing and differential expression in chondrocytes (Hauer et al., 2019). Possibly sharing a similar mechanism, Adam12, a candidate gene in both a diet-independent and diet-dependent locus on chromosome 7, is known to play an important role in the differentiation, proliferation, and maturation of chondrocytes (Horita et al., 2019).

Future considerations

To summarize, we found that the effects of age and diet on body weight differ substantially with respect to the genetic background and type of dietary intervention imposed. These results highlight that with knowledge of these environment-dependent effects, we can generate more accurate predictions of body weight trajectories than would be possible from knowledge of genotype, age, or diet alone. Moreover, with the elucidation of specific candidate genes and variants underlying these effects, we are not limited to predicting how this complex quantitative trait changes with age, but can also identify specific targets for genetic or pharmacological manipulation in an effort to improve organismal health.

One important limitation to our study is the lack of direct measurements of food consumption and feeding behaviors for each mouse in the population; this makes it difficult to ascertain how much variation in body weight can be ascribed to variation in such behaviors. Additionally, CR was imposed based on the average food consumed by a typical DO mouse rather than a per-mouse baseline of food consumption. Furthermore, CR interventions were imposed on a per-cage basis, not a per-mouse basis, because all animals were housed in groups of eight. Therefore, the social hierarchy within each cage likely contributed to additional variation in body weight (Baud et al., 2017). Additionally, we note that over the course of this study each animal underwent a number of phenotypic assays (Figure 1—figure supplement 1) that would further contribute to study-specific variation in body weight. Accounting for these sources of variation will be a promising avenue for future research, helping interpret many of the associations identified in our study.

A second important consideration for this study is the potential for survival bias to lead to inflated PVE values and false-positive associations at later ages. To evaluate the presence of survival bias, we computed PVE at all ages restricting to animals that survived to 660 days of age (75% of animals in our study). We observed similar PVE values to those from the full dataset, across the full age range, suggesting that survival bias has very little effect on the results presented in this paper (Figure 4—figure supplement 3C, top-left panel). However, as these animals age and the survival bias of the population increases, genetic analyses of body weight at ages past 660 days will need to explicitly account for this effect.

In this study, we have elucidated the dynamics and context dependence of the genetic architecture of body weight from 60 to 660 days of age. By 660 days of age, nearly all surviving animals have realized their maximum adult body weight and the majority of animals have yet to experience appreciable loss of body weight indicative of late-age physiological decline. Under AL diet, reduced body weight has been associated with greater longevity, whereas under 40% CR conditions, greater longevity is associated with the maintenance of high body weight (Liao et al., 2011). Our future research will assess whether we observe a similar result in this DO population and determine whether alleles at body weight loci are predictive of life span in a diet-dependent manner.

Materials and methods

Polygenic models for gene × environment interactions

G×EMM (Dahl et al., 2020) is a generalization of the standard linear mixed model that allows for polygenic G×E effects. Under this model, the phenotype is written in terms of genetic effects as follows:

Y=α0+e=1EZeαe+v=1VGvβv+e=1Ev=1VGvZeγve+ε, (1)

where YRN is the vector of phenotypes over N samples, Gv,v=1,,V are genotypes of V biallelic SNPs, Ze,e=1,,E are binary vectors over E environments, and ε denotes the residual vector.

In our application, Y is the vector of 1 trend filtered body weights at a specific age; we do not standardize the body weights so that the estimated effects are interpretable and comparable across ages. When testing for association with the founder-of-origin of markers, Gnv[0,1]8;Gnv1=1 is a vector denoting the probability that the two alleles of the marker came from each of the eight founder lines from which the DO population is derived. 1 denotes the L1-norm of a vector. Alternatively, when testing for association with the allele dosage of a variant, Gnv[0,2] is the expected allele count at variant v. Finally, Zne=1 denotes that sample n is subject to environment e. Prior to dietary intervention, the environments in our model are the 12 generations over which the DO samples span (i.e., E=12). After dietary intervention, the environments further include the five diet groups (i.e., E=17).

The effects of covariates, α, are modeled as fixed while the genetic effects, β, and genotype–environment effects, γ, are modeled as random. Assuming heteroscedastic noise, εN(0,Θ), a normal prior on the random genetic effects, βvN(0,ϱ2/V), and a normal prior on the random G×E effects, γvN(0,1VΩ), we get YN(μ,Λ), where μ=α0+eZeαe and Λ=Θ+ϱ2K+e,eΩee(K(ZeZeT)) is a diagonal matrix with entries specified as Θnn=eZne2σe2, K is the kinship matrix with entries defined as Kmn=1VvGmvTGnv, ϱ2 is the variance of environment-independent genetic effects, ΩE×E is the variance–covariance matrix representing the co-variation in environment-dependent genetic effects between pairs of environments, and AB denotes the Hadamard product of matrices A and B. We do not include an environment-independent noise term since it is nonidentifiable.

Off-diagonal elements of Ω quantify the covariance in the interaction effect sizes between pairs of environments; thus, a diagonal Ω assumes that the interaction effect sizes between pairs of environments are uncorrelated. This assumption of diagonal Ω could lead to some bias in the estimates of the variance components, although bias in PVE estimates are expected to be minimal. We computed PVE estimates using a full Ω and a diagonal Ω and observed little difference (Figure 4—figure supplement 5). For the sake of computational simplicity, we assumed all off-diagonal elements of Ω to be zero in this study. Note that each of the above parameters and data vectors in the model may be distinct at different ages.

Recent work has shown that non-negativity constraints on the variance components are both important in order to obtain unbiased estimates and unnecessary to achieve valid estimates of heritability (Steinsaltz et al., 2020). Nevertheless, we constrained the variance components to be non-negative since they are more interpretable in the context of our study. While it is likely that this constraint contributes to the small bias observed in our simulations (Figure 3), we observed almost no bias in heritability estimates for body weight due to the constraint, likely because of strong signals in the data (Figure 4—figure supplement 4). We have also included a flag in our published code to relax this constraint when estimating the variance components.

Proportion of phenotypic variance explained by genetics

Decomposing the phenotype into genetic and nongenetic effects, Y=YG+Yε, the expected proportion of phenotypic variance explained by genetic effects is approximately given as

PVE=E[V[YG]V[Y]]E[V[YG]]E[V[Y]]VarGVarY, (2)

where V[] denotes the sample variance. The expected sample phenotypic variance conditional on environment e can be written as

E[V[Y|e]]=E[nYn2Zne]Ne-E[(nYnZne)2]Ne2, (3)

where Zne is an indicator variable denoting whether sample n belongs to environment e, and Ne=nZne is the number of samples in environment e. Under the G×EMM model, starting from Equation 1 and integrating out the random effects, we can write the numerator of the first term in the expectation as

E[nYn2Zne]=nμn2Zne+ϱ2Vn,vGnv2Zne+e,e′′Ωee′′Vn,vGnv2ZneZneZne′′+nΘnnZne, (4)

and the numerator of the second term in the expectation as

E[(nYnZne)2]=(nμnZne)2+ϱ2Vvn,nGnvGnvZneZne+e,e′′Ωee′′Vvn,nGnvGnvZn,eZne′′ZneZne+nΘnnZne, (5)

where e and e′′ iterate over all environments and n and n′′ iterate over all samples. Therefore, the expected sample phenotypic variance can be decomposed as follows:

E[V[Y|e]]=(nμn2ZneNe(nμnZne)2Ne2)+ϱ2(tr(KWe)Nesum(KWe)Ne2)+eΩee(tr(KWeWe)Nesum(KWeWe)Ne2)+tr(ΘWe)(Ne1Ne2), (6)

where We=ZeZeT, tr() denotes that trace of a matrix, sum() denotes the sum of all entries of the matrix, and AB denotes the Hadamard product of matrices A and B. The first term quantifies the phenotypic variance explained by fixed effects, the second and third terms together quantify the phenotypic variance explained by genetic effects (E[V[YG|e]]), and the fourth term quantifies the residual (unexplained) phenotypic variance. The total proportion of variance explained by genetics in the entire sample can now be computed using Equation 2.

PVEtot=VarGVarY, (7)
VarG=ϱ2(tr(K)Nsum(K)N2)+eΩee(tr(KWe)Nsum(KWe)N2), (8)
VarY=VarG+((nμn2)N-(nμn)2N2)+tr(Θ)(N-1N2). (9)

The two terms in VarG are genetic contributions to phenotypic variation that are shared across environments and specific to environments, respectively. The second and third terms in VarY are phenotypic variation explained by fixed effects and unexplained residual phenotypic variation, respectively.

The expected total sample phenotypic variance (across all environments) again has two terms, as in Equation 3; the numerator of the first term is written as

E[nYn2]=nμn2+ϱ2VnvGnv2+e,eΩeeVnvGnv2ZneZne+nΘnn, (10)

and the numerator of the second term is written as

E[(nYn)2]=(nμn)2+ϱ2Vvn,nGnvGnv+e,eΩeeVvn,nGnvGnvZneZne+nΘnn. (11)

The expected total sample phenotypic variance can be decomposed as follows:

E[V[Y]]=(nμn2N(nμn)2N2)+ϱ2(tr(K)Nsum(K)N2)+eΩee(tr(KWe)Nsum(KWe)N2)+tr(Θ)(N1N2). (12)

The proportion of variance explained by genetics conditional on environment can be computed by substituting the above in Equation 2.

PVEe=VarG|eVarY|e, (13)
VarG|e=ϱ2(tr(KWe)Nesum(KWe)Ne2)+eΩee(tr(KWeWe)Nesum(KWeWe)Ne2), (14)
VarY|e=VarG|e+((nμn2Zne)Ne-(nμnZne)2Ne2)+tr(ΘWe)(Ne-1Ne2). (15)

The proportion of phenotypic variance explained by genetic effects is equivalent to narrow-sense heritability, once variation due to additive effects of environment, batch, and other study design artifacts have been removed. In this work, we use the more general term, proportion of variance explained, to accommodate variation due to effects of diet and environment.

Under the EMMA model, the expected total sample phenotypic variance simplifies to

E[V[Y]]=(nμn2N(nμn)2N2)+ϱ2(tr(K)Nsum(K)N2)+θ2(N1N2), (16)

where θ denotes the homoscedastic noise. The first component quantifies the phenotypic variance explained by fixed effects, the second component quantifies the phenotypic variance explained by genetic effects (E[V[YG]]), and the third component quantifies the residual (unexplained) phenotypic variance. Substituting these into Equation 2 gives us the proportion of variance explained by genetics under the EMMA model.

Genome-wide association mapping

Additive genetic effects

To test for additive effect of a genetic variant on the phenotype, we include the focal variant among the fixed effects in the model while treating all other variants to have random effects.

Y=cXcαc+ϕsGs+vsGvβv+v,eGvZeγve+ε (17)

Applying the priors described above for βv, γv, and ε, we can derive the corresponding mixed-effects model is as follows:

YN(cXcαc+ϕsGs,Λs), (18)

where Λs=Θ+ϱ2Ks+eΩee(KsWe) and Ks is the kinship matrix after excluding the entire chromosome containing the variant s (leave-one-chromosome-out [LOCO] kinship). Leaving out the focal chromosome when computing kinship increases our power to detect associations at the focal variant (Lippert et al., 2011). The test statistic is the log likelihood ratio Φa(Y,Gs) comparing the alternate model :ϕs0 to the null model 0:ϕs=0.

Φa(Y,Gs)=logmax(ϕs,α,σ,ϱ,Ω)max(ϕs=0,α,σ,ϱ,Ω) (19)

Genotype–environment effects

To test for effects of interaction between genotype and environment on the phenotype, we include a fixed effect for the focal variant and its interactions with the set of all environments of interest () while treating all other variants to have random effects for their additive and interaction contributions:

Y=cXcαc+ϕsGs+eχseGsZe+vsGvβv+vs,eGvZeγve+ε. (20)

The corresponding mixed-effects model is

YN(cαcXc+ϕsGs+eEχseGsZe,Λs), (21)

and the test statistic is:

Φi(Y,Gs)=logmaxL(χs,ϕs,α,σ,ϱ,Ω)maxL(χs=0,ϕs,α,σ,ϱ,Ω), (22)

where Xs is a vector notation for all χse. Note that this statistic tests for the presence of interaction effects between the focal variant and any of the environments of interest.

Likelihood and gradients for G×EMM model

Under the full G×EMM model, the phenotype Y depends on fixed and random effects as follows:

YN(μ,Λ), (23)

where μ=α0+eZeαe captures all fixed effects and Λ=Θ+ϱ2K+eΩeeK(ZeZeT) captures the covariance after integrating out the random effects. The parameters to be estimated in this model are α, σ, ϱ, and Ω. The complete log likelihood can be written as

=-N2log(2π)-12logdetΛ-12(Y-Xα)TΛ-1(Y-Xα). (24)

Maximizing the log likelihood over α gives us

α^=argmaxα=(XTΛ-1X)-1(XTΛ-1Y). (25)

Substituting this into the log likelihood, we get

Lα^=N2log(2π)12logdetΛ12YTPY, (26)

where P=Λ1Λ1X(XTΛ1X)1XTΛ1.

Computing the gradient of α^ involves evaluating the following gradients:

Λσe2=IZe (27)
Λϱ2=K (28)
ΛΩee=K(ZeZeT) (29)
logdetΛ=tr(Λ1Λ) (30)
Λ1=Λ1ΛΛ1 (31)
P=PΛP, (32)

where Ze is a diagonal matrix with elements of the vector Ze on the diagonal. Thus,

Lα^σe2=12tr(Λ1IZe)+12YTPIZePY (33)
Lα^ϱ2=12tr(Λ1K)+12YTPKPY (34)
Lα^Ωee=12tr(Λ1Ke)+12YTPKePY, (35)

where Ke=K(ZeZeT).

Permutations

Since the assumptions underlying the G×EMM model are unlikely to hold exactly in practice, we used permutations to assess the significance of the observed values of Φa and Φi. Specifically, for each variant s, we generated M independent random permutations μ1,,μM of (1,,N) and computed test statistics Φma/iΦa/i(μm(Y),Gs) for each permutation μm. The p-value associated with Φa and Φi is then given as

pa/i=#{m:Φma/iΦa/i}+1M+1 (36)

We used a sequential procedure (Besag and Clifford, 1991; Shim and Stephens, 2015) to compute the p-value that helps avoid large numbers of permutations for nonsignificant results, substantially speeding up computation. Specifically, instead of a fixed large number of permutations M, we performed Ms permutations for each variant s until Csa/i#{m:Λma/iΛa/i}=10 or Ms=108. The p-value for the sth variant is then a random sample from the interval [CsMs,Cs+1Ms+1]. This scheme allows us to estimate p-value quickly without carrying out large numbers of permutations at every marker. Although the precision of this estimate is lower for markers that are not significant (i.e., most of the genome), precision increases as the significance of association increases.

Tests for nonlinearity in trends of effect size with age

We test for nonlinear dependence between effect size and age by comparing two models: a null model that only allows for linear dependence between age and effect size and an alternate model that allows for dependence between effect size and higher-order powers of age. While this test can be applied to evaluate nonlinear effect-size trends for any covariate (e.g., dietary intervention, genotype, etc.), we focus our attention to tests for nonlinear trends in the effect sizes of the founder alleles and the effect sizes of the interaction between founder alleles and diet.

Specifically, the estimated effects ϕ^st and their standard errors ψ^st can be modeled as

ϕ^stN(ϕst,ψ^st);t{40,50,,660} (37)

and the two models of the effect size trends are

Hn:ϕst=φ0+φ1t+φ2t2+φ3t3H:ϕst=φ0+φ1t, (38)

where t denotes the ages (in days) at which we test for association between a genetic variant and body weight and ϕst the unobserved effect sizes at these ages. We used a likelihood ratio test statistic () to compare the two models and quantify the evidence for nonlinearity in effect size trends with age and assessed significance using p-values computed using a chi-squared distribution with degree-of-freedom 2.

=2lnmaxL(φ)maxL(φ;φ2=φ3=0), (39)

where (φ) is the likelihood under the model in Equation 37.

We apply this test for each of the founder effects in each of the 14 diet-independent loci (112 tests) and each of the 19 founder-x-diet interaction effects in each of the diet-dependent loci (760 tests). We assign a diet-independent trend as significantly nonlinear if we observe a p<104 and assign a diet-dependent trend as significantly nonlinear if we observe a p<105 (Bonferroni-corrected p-value thresholds).

Data and software release

Data used in this study, and significant QTLs, can be downloaded from the following links:

Our Python implementation of the EMMA and G×EMM models can be downloaded from https://github.com/calico/do_qtl; (Raj, 2021; copy archived at swh:1:rev:3d23d3fbd7768b74b0bba6183de1570a65a2d93d).

Acknowledgements

The authors acknowledge Madeleine Cule, Anastasia Baryshnikova, Dale Zhang, and Nicholas Bernstein for their comments on the article and reviewing the software developed for all analyses, and Adam Baker for helping with the design of Table 1. The authors would also like to acknowledge Amelie Baud, Andrew Dahl, and an anonymous reviewer for their insightful comments and suggestions that helped greatly improve our article.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Gary A Churchill, Email: gary.churchill@jax.org.

Anil Raj, Email: anil@calicolabs.com.

Sara Hägg, Karolinska Institutet, Sweden.

Naama Barkai, Weizmann Institute of Science, Israel.

Funding Information

This paper was supported by the following grant:

  • Calico Life Sciences LLC to Kevin M Wright, Andrew G Deighan, Andrea Di Francesco, Adam Freund, Vladimir Jojic, Gary A Churchill, Anil Raj.

Additional information

Competing interests

Kevin is an employee of Calico Life Sciences LLC.

No competing interests declared.

Andrea is an employee of Calico Life Sciences LLC.

Adam is an employee of Calico Life Sciences LLC.

Vladimir is an employee of Calico Life Sciences LLC.

Anil is an employee of Calico Life Sciences LLC.

Author contributions

Conceptualization, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft.

Data curation, Resources.

Validation, Writing - review and editing.

Funding acquisition, Project administration, Supervision.

Methodology, Software, Writing - review and editing.

Conceptualization, Funding acquisition, Project administration, Resources, Writing - review and editing.

Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Supervision, Validation, Visualization, Writing – original draft.

Ethics

All animal procedures were reviewed and approved by the Jackson Laboratory Animal Care and Use Committee (summary # 06005).

Additional files

Transparent reporting form

Data availability

All data used in the study, and results of analyses, are publicly available at https://figshare.com/projects/Age_and_diet_shape_the_genetic_architecture_of_body_weight_in_Diversity_Outbred_mice/92201.

The following datasets were generated:

Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Genotype data: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare.

Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Phenotype data: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare.

Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Results: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare.

Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Covariate data: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare.

References

  1. Abney M. Permutation testing in the presence of polygenic variation. Genetic Epidemiology. 2015;39:249–258. doi: 10.1002/gepi.21893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aylor DL, Valdar W, Foulds-Mathes W, Buus RJ, Verdugo RA, Baric RS, Ferris MT, Frelinger JA, Heise M, Frieman MB, Gralinski LE, Bell TA, Didion JD, Hua K, Nehrenberg DL, Powell CL, Steigerwalt J, Xie Y, Kelada SNP, Collins FS, Yang IV, Schwartz DA, Branstetter LA, Chesler EJ, Miller DR, Spence J, Liu EY, McMillan L, Sarkar A, Wang J, Wang W, Zhang Q, Broman KW, Korstanje R, Durrant C, Mott R, Iraqi FA, Pomp D, Threadgill D, de Villena FP-M, Churchill GA. Genetic analysis of complex traits in the emerging Collaborative Cross. Genome Research. 2011;21:1213–1222. doi: 10.1101/gr.111310.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baud A, Mulligan MK, Casale FP, Ingels JF, Bohl CJ, Callebert J, Launay JM, Krohn J, Legarra A, Williams RW, Stegle O. Genetic Variation in the Social Environment Contributes to Health and Disease. PLOS Genetics. 2017;13:e1006498. doi: 10.1371/journal.pgen.1006498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. 1995;57:289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x. [DOI] [Google Scholar]
  5. Besag J, Clifford P. Sequential monte carlo p-values. Biometrika. 1991;78:301–304. doi: 10.1093/biomet/78.2.301. [DOI] [Google Scholar]
  6. Braccini L, Ciraolo E, Campa CC, Perino A, Longo DL, Tibolla G, Pregnolato M, Cao Y, Tassone B, Damilano F, Laffargue M, Calautti E, Falasca M, Norata GD, Backer JM, Hirsch E. PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling. Nature Communications. 2015;6:7400. doi: 10.1038/ncomms8400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Broman KW, Gatti DM, Simecek P, Furlotte NA, Prins P, Sen Ś, Yandell BS, Churchill GA. R/qtl2: Software for Mapping Quantitative Trait Loci with High-Dimensional Data and Multiparent Populations. Genetics. 2019;211:495–502. doi: 10.1534/genetics.118.301595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bulik-Sullivan BK, Loh P-R, Finucane HK, Ripke S, Yang J, Schizophrenia Working Group of the Psychiatric Genomics Consortium. Patterson N, Daly MJ, Price AL, Neale BM. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nature Genetics. 2015;47:291–295. doi: 10.1038/ng.3211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheverud JM, Routman EJ, Duarte FA, van Swinderen B, Cothran K, Perel C. Quantitative trait loci for murine growth. Genetics. 1996;142:1305–1319. doi: 10.1093/genetics/142.4.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Couto Alves A, De Silva NMG, Karhunen V, Sovio U, Das S, Taal HR, Warrington NM, Lewin AM, Kaakinen M, Cousminer DL, Thiering E, Timpson NJ, Bond TA, Lowry E, Brown CD, Estivill X, Lindi V, Bradfield JP, Geller F, Speed D, Coin LJM, Loh M, Barton SJ, Beilin LJ, Bisgaard H, Bønnelykke K, Alili R, Hatoum IJ, Schramm K, Cartwright R, Charles M-A, Salerno V, Clément K, Claringbould AAJ, BIOS Consortium. van Duijn CM, Moltchanova E, Eriksson JG, Elks C, Feenstra B, Flexeder C, Franks S, Frayling TM, Freathy RM, Elliott P, Widén E, Hakonarson H, Hattersley AT, Rodriguez A, Banterle M, Heinrich J, Heude B, Holloway JW, Hofman A, Hyppönen E, Inskip H, Kaplan LM, Hedman AK, Läärä E, Prokisch H, Grallert H, Lakka TA, Lawlor DA, Melbye M, Ahluwalia TS, Marinelli M, Millwood IY, Palmer LJ, Pennell CE, Perry JR, Ring SM, Savolainen MJ, Rivadeneira F, Standl M, Sunyer J, Tiesler CMT, Uitterlinden AG, Schierding W, O’Sullivan JM, Prokopenko I, Herzig K-H, Smith GD, O’Reilly P, Felix JF, Buxton JL, Blakemore AIF, Ong KK, Jaddoe VWV, Grant SFA, Sebert S, McCarthy MI, Järvelin M-R, Early Growth Genetics (EGG) Consortium GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI. Science Advances. 2019;5:eaaw3095. doi: 10.1126/sciadv.aaw3095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cusanovich DA, Hill AJ, Aghamirzaie D, Daza RM, Pliner HA, Berletch JB, Filippova GN, Huang X, Christiansen L, DeWitt WS, Lee C, Regalado SG, Read DF, Steemers FJ, Disteche CM, Trapnell C, Shendure J. A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility. Cell. 2018;174:1309–1324. doi: 10.1016/j.cell.2018.06.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dahl A, Nguyen K, Cai N, Gandal MJ, Flint J, Zaitlen N. A Robust Method Uncovers Significant Context-Specific Heritability in Diverse Complex Traits. American Journal of Human Genetics. 2020;106:71–91. doi: 10.1016/j.ajhg.2019.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gao X, Becker LC, Becker DM, Starmer JD, Province MA. Avoiding the high Bonferroni penalty in genome-wide association studies. Genetic Epidemiology. 2010;34:100–105. doi: 10.1002/gepi.20430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gorkin DU, Barozzi I, Zhao Y, Zhang Y, Huang H, Lee AY, Li B, Chiou J, Wildberg A, Ding B, Zhang B, Wang M, Strattan JS, Davidson JM, Qiu Y, Afzal V, Akiyama JA, Plajzer-Frick I, Novak CS, Kato M, Garvin TH, Pham QT, Harrington AN, Mannion BJ, Lee EA, Fukuda-Yuzawa Y, He Y, Preissl S, Chee S, Han JY, Williams BA, Trout D, Amrhein H, Yang H, Cherry JM, Wang W, Gaulton K, Ecker JR, Shen Y, Dickel DE, Visel A, Pennacchio LA, Ren B. An atlas of dynamic chromatin landscapes in mouse fetal development. Nature. 2020;583:744–751. doi: 10.1038/s41586-020-2093-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gray MM, Parmenter MD, Hogan CA, Ford I, Cuthbert RJ, Ryan PG, Broman KW, Payseur BA. Genetics of Rapid and Extreme Size Evolution in Island Mice. Genetics. 2015;201:213–228. doi: 10.1534/genetics.115.177790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hashimoto T, Yamada M, Maekawa S, Nakashima T, Miyata S. IgLON cell adhesion molecule Kilon is a crucial modulator for synapse number in hippocampal neurons. Brain Research. 2008;1224:1–11. doi: 10.1016/j.brainres.2008.05.069. [DOI] [PubMed] [Google Scholar]
  17. Hauer NN, Popp B, Taher L, Vogl C, Dhandapany PS, Büttner C, Uebe S, Sticht H, Ferrazzi F, Ekici AB, De Luca A, Klinger P, Kraus C, Zweier C, Wiesener A, Jamra RA, Kunstmann E, Rauch A, Wieczorek D, Jung A-M, Rohrer TR, Zenker M, Doerr H-G, Reis A, Thiel CT. Evolutionary conserved networks of human height identify multiple Mendelian causes of short stature. European Journal of Human Genetics. 2019;27:1061–1071. doi: 10.1038/s41431-019-0362-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Horita M, Nishida K, Hasei J, Furumatsu T, Sakurai M, Onodera Y, Fukuda K, Salter DM, Ozaki T. Involvement of ADAM12 in Chondrocyte Differentiation by Regulation of TGF-β1-Induced IGF-1 and RUNX-2 Expressions. Calcified Tissue International. 2019;105:97–106. doi: 10.1007/s00223-019-00549-6. [DOI] [PubMed] [Google Scholar]
  19. Hyde CL, Nagle MW, Tian C, Chen X, Paciga SA, Wendland JR, Tung JY, Hinds DA, Perlis RH, Winslow AR. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nature Genetics. 2016;48:1031–1036. doi: 10.1038/ng.3623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kang HM, Zaitlen NA, Wade CM, Kirby A, Heckerman D, Daly MJ, Eskin E. Efficient control of population structure in model organism association mapping. Genetics. 2008;178:1709–1723. doi: 10.1534/genetics.107.080101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Keane TM, Goodstadt L, Danecek P, White MA, Wong K, Yalcin B, Heger A, Agam A, Slater G, Goodson M, Furlotte NA, Eskin E, Nellåker C, Whitley H, Cleak J, Janowitz D, Hernandez-Pliego P, Edwards A, Belgard TG, Oliver PL, McIntyre RE, Bhomra A, Nicod J, Gan X, Yuan W, van der Weyden L, Steward CA, Bala S, Stalker J, Mott R, Durbin R, Jackson IJ, Czechanski A, Guerra-Assunção JA, Donahue LR, Reinholdt LG, Payseur BA, Ponting CP, Birney E, Flint J, Adams DJ. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature. 2011;477:289–294. doi: 10.1038/nature10413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kim SJ, Koh K, Boyd S, Gorinevsky D. l1 trend filtering. SIAM Review. 2009;51:339–360. doi: 10.1137/070690274. [DOI] [Google Scholar]
  23. Lee AWS, Hengstler H, Schwald K, Berriel-Diaz M, Loreth D, Kirsch M, Kretz O, Haas CA, de Angelis MH, Herzig S, Brümmendorf T, Klingenspor M, Rathjen FG, Rozman J, Nicholson G, Cox RD, Schäfer MKE. Functional inactivation of the genome-wide association study obesity gene neuronal growth regulator 1 in mice causes a body mass phenotype. PLOS ONE. 2012;7:e41537. doi: 10.1371/journal.pone.0041537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liao CY, Rikke BA, Johnson TE, Gelfond JAL, Diaz V, Nelson JF. Fat maintenance is a predictor of the murine lifespan response to dietary restriction. Aging Cell. 2011;10:629–639. doi: 10.1111/j.1474-9726.2011.00702.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lincoln SE, Lander ES. Systematic detection of errors in genetic linkage data. Genomics. 1992;14:604–610. doi: 10.1016/s0888-7543(05)80158-2. [DOI] [PubMed] [Google Scholar]
  26. Lippert C, Listgarten J, Liu Y, Kadie CM, Davidson RI, Heckerman D. FaST linear mixed models for genome-wide association studies. Nature Methods. 2011;8:833–835. doi: 10.1038/nmeth.1681. [DOI] [PubMed] [Google Scholar]
  27. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J, Croteau-Chonka DC, Esko T, Fall T, Ferreira T, Gustafsson S, Kutalik Z, Luan J, Mägi R, Randall JC, Winkler TW, Wood AR, Workalemahu T, Faul JD, Smith JA, Zhao JH, Zhao W, Chen J, Fehrmann R, Hedman ÅK, Karjalainen J, Schmidt EM, Absher D, Amin N, Anderson D, Beekman M, Bolton JL, Bragg-Gresham JL, Buyske S, Demirkan A, Deng G, Ehret GB, Feenstra B, Feitosa MF, Fischer K, Goel A, Gong J, Jackson AU, Kanoni S, Kleber ME, Kristiansson K, Lim U, Lotay V, Mangino M, Leach IM, Medina-Gomez C, Medland SE, Nalls MA, Palmer CD, Pasko D, Pechlivanis S, Peters MJ, Prokopenko I, Shungin D, Stančáková A, Strawbridge RJ, Sung YJ, Tanaka T, Teumer A, Trompet S, van der Laan SW, van Setten J, Van Vliet-Ostaptchouk JV, Wang Z, Yengo L, Zhang W, Isaacs A, Albrecht E, Ärnlöv J, Arscott GM, Attwood AP, Bandinelli S, Barrett A, Bas IN, Bellis C, Bennett AJ, Berne C, Blagieva R, Blüher M, Böhringer S, Bonnycastle LL, Böttcher Y, Boyd HA, Bruinenberg M, Caspersen IH, Chen Y-DI, Clarke R, Daw EW, de Craen AJM, Delgado G, Dimitriou M, Doney ASF, Eklund N, Estrada K, Eury E, Folkersen L, Fraser RM, Garcia ME, Geller F, Giedraitis V, Gigante B, Go AS, Golay A, Goodall AH, Gordon SD, Gorski M, Grabe H-J, Grallert H, Grammer TB, Gräßler J, Grönberg H, Groves CJ, Gusto G, Haessler J, Hall P, Haller T, Hallmans G, Hartman CA, Hassinen M, Hayward C, Heard-Costa NL, Helmer Q, Hengstenberg C, Holmen O, Hottenga J-J, James AL, Jeff JM, Johansson Å, Jolley J, Juliusdottir T, Kinnunen L, Koenig W, Koskenvuo M, Kratzer W, Laitinen J, Lamina C, Leander K, Lee NR, Lichtner P, Lind L, Lindström J, Lo KS, Lobbens S, Lorbeer R, Lu Y, Mach F, Magnusson PKE, Mahajan A, McArdle WL, McLachlan S, Menni C, Merger S, Mihailov E, Milani L, Moayyeri A, Monda KL, Morken MA, Mulas A, Müller G, Müller-Nurasyid M, Musk AW, Nagaraja R, Nöthen MM, Nolte IM, Pilz S, Rayner NW, Renstrom F, Rettig R, Ried JS, Ripke S, Robertson NR, Rose LM, Sanna S, Scharnagl H, Scholtens S, Schumacher FR, Scott WR, Seufferlein T, Shi J, Smith AV, Smolonska J, Stanton AV, Steinthorsdottir V, Stirrups K, Stringham HM, Sundström J, Swertz MA, Swift AJ, Syvänen A-C, Tan S-T, Tayo BO, Thorand B, Thorleifsson G, Tyrer JP, Uh H-W, Vandenput L, Verhulst FC, Vermeulen SH, Verweij N, Vonk JM, Waite LL, Warren HR, Waterworth D, Weedon MN, Wilkens LR, Willenborg C, Wilsgaard T, Wojczynski MK, Wong A, Wright AF, Zhang Q, Brennan EP, Choi M, Dastani Z, Drong AW, Eriksson P, Franco-Cereceda A, Gådin JR, Gharavi AG, Goddard ME, Handsaker RE, Huang J, Karpe F, Kathiresan S, Keildson S, Kiryluk K, Kubo M, Lee J-Y, Liang L, Lifton RP, Ma B, McCarroll SA, McKnight AJ, Min JL, Moffatt MF, Montgomery GW, Murabito JM, Nicholson G, Nyholt DR, Okada Y, Perry JRB, Dorajoo R, Reinmaa E, Salem RM, Sandholm N, Scott RA, Stolk L, Takahashi A, Tanaka T, van ’t Hooft FM, Vinkhuyzen AAE, Westra H-J, Zheng W, Zondervan KT, Heath AC, Arveiler D, Bakker SJL, Beilby J, Bergman RN, Blangero J, Bovet P, Campbell H, Caulfield MJ, Cesana G, Chakravarti A, Chasman DI, Chines PS, Collins FS, Crawford DC, Cupples LA, Cusi D, Danesh J, de Faire U, den Ruijter HM, Dominiczak AF, Erbel R, Erdmann J, Eriksson JG, Farrall M, Felix SB, Ferrannini E, Ferrières J, Ford I, Forouhi NG, Forrester T, Franco OH, Gansevoort RT, Gejman PV, Gieger C, Gottesman O, Gudnason V, Gyllensten U, Hall AS, Harris TB, Hattersley AT, Hicks AA, Hindorff LA, Hingorani AD, Hofman A, Homuth G, Hovingh GK, Humphries SE, Hunt SC, Hyppönen E, Illig T, Jacobs KB, Jarvelin M-R, Jöckel K-H, Johansen B, Jousilahti P, Jukema JW, Jula AM, Kaprio J, Kastelein JJP, Keinanen-Kiukaanniemi SM, Kiemeney LA, Knekt P, Kooner JS, Kooperberg C, Kovacs P, Kraja AT, Kumari M, Kuusisto J, Lakka TA, Langenberg C, Marchand LL, Lehtimäki T, Lyssenko V, Männistö S, Marette A, Matise TC, McKenzie CA, McKnight B, Moll FL, Morris AD, Morris AP, Murray JC, Nelis M, Ohlsson C, Oldehinkel AJ, Ong KK, Madden PAF, Pasterkamp G, Peden JF, Peters A, Postma DS, Pramstaller PP, Price JF, Qi L, Raitakari OT, Rankinen T, Rao DC, Rice TK, Ridker PM, Rioux JD, Ritchie MD, Rudan I, Salomaa V, Samani NJ, Saramies J, Sarzynski MA, Schunkert H, Schwarz PEH, Sever P, Shuldiner AR, Sinisalo J, Stolk RP, Strauch K, Tönjes A, Trégouët D-A, Tremblay A, Tremoli E, Virtamo J, Vohl M-C, Völker U, Waeber G, Willemsen G, Witteman JC, Zillikens MC, Adair LS, Amouyel P, Asselbergs FW, Assimes TL, Bochud M, Boehm BO, Boerwinkle E, Bornstein SR, Bottinger EP, Bouchard C, Cauchi S, Chambers JC, Chanock SJ, Cooper RS, de Bakker PIW, Dedoussis G, Ferrucci L, Franks PW, Froguel P, Groop LC, Haiman CA, Hamsten A, Hui J, Hunter DJ, Hveem K, Kaplan RC, Kivimaki M, Kuh D, Laakso M, Liu Y, Martin NG, März W, Melbye M, Metspalu A, Moebus S, Munroe PB, Njølstad I, Oostra BA, Palmer CNA, Pedersen NL, Perola M, Pérusse L, Peters U, Power C, Quertermous T, Rauramaa R, Rivadeneira F, Saaristo TE, Saleheen D, Sattar N, Schadt EE, Schlessinger D, Slagboom PE, Snieder H, Spector TD, Thorsteinsdottir U, Stumvoll M, Tuomilehto J, Uitterlinden AG, Uusitupa M, van der Harst P, Walker M, Wallaschofski H, Wareham NJ, Watkins H, Weir DR, Wichmann H-E, Wilson JF, Zanen P, Borecki IB, Deloukas P, Fox CS, Heid IM, O’Connell JR, Strachan DP, Stefansson K, van Duijn CM, Abecasis GR, Franke L, Frayling TM, McCarthy MI, Visscher PM, Scherag A, Willer CJ, Boehnke M, Mohlke KL, Lindgren CM, Beckmann JS, Barroso I, North KE, Ingelsson E, Hirschhorn JN, Loos RJF, Speliotes EK, LifeLines Cohort Study. ADIPOGen Consortium. AGEN-BMI Working Group. CARDIOGRAMplusC4D Consortium. CKDGen Consortium. GLGC. ICBP. MAGIC Investigators. MuTHER Consortium. MIGen Consortium. PAGE Consortium. ReproGen Consortium. GENIE Consortium. International Endogene Consortium Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206. doi: 10.1038/nature14177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Miyata S, Matsumoto N, Taguchi K, Akagi A, Iino T, Funatsu N, Maekawa S. Biochemical and ultrastructural analyses of IgLON cell adhesion molecules, Kilon and OBCAM in the rat brain. Neuroscience. 2003;117:645–658. doi: 10.1016/s0306-4522(02)00873-4. [DOI] [PubMed] [Google Scholar]
  29. Moore R, Casale FP, Jan Bonder M, Horta D, Consortium B, Franke L, Barroso I, Stegle O. A linear mixed-model approach to study multivariate gene-environment interactions. Nature Genetics. 2019;51:180–186. doi: 10.1038/s41588-018-0271-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Morgan AP, Fu CP, Kao CY, Welsh CE, Didion JP, Yadgary L, Hyacinth L, Ferris MT, Bell TA, Miller DR, Giusti-Rodriguez P, Nonneman RJ, Cook KD, Whitmire JK, Gralinski LE, Keller M, Attie AD, Churchill GA, Petkov P, Sullivan PF, Brennan JR, McMillan L, Pardo-Manuel de Villena F. The Mouse Universal Genotyping Array: From Substrains to Subspecies. G3: Genes, Genomes, Genetics. 2015;6:263–279. doi: 10.1534/g3.115.022087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Parker CC, Gopalakrishnan S, Carbonetto P, Gonzales NM, Leung E, Park YJ, Aryee E, Davis J, Blizard DA, Ackert-Bicknell CL, Lionikas A, Pritchard JK, Palmer AA. Genome-wide association study of behavioral, physiological and gene expression traits in outbred CFW mice. Nature Genetics. 2016;48:919–926. doi: 10.1038/ng.3609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Raj A. do_qtl. swh:1:rev:3d23d3fbd7768b74b0bba6183de1570a65a2d93dSoftware Heritage. 2021 https://archive.softwareheritage.org/swh:1:dir:a1752d8ad855e89f8e3ab193635f399b0e263c28;origin=https://github.com/calico/do_qtl;visit=swh:1:snp:e652530437f01c18041f0267a5b315ef0cafd826;anchor=swh:1:rev:3d23d3fbd7768b74b0bba6183de1570a65a2d93d
  33. Rikke BA, Battaglia ME, Allison DB, Johnson TE. Murine weight loss exhibits significant genetic variation during dietary restriction. Physiological Genomics. 2006;27:122–130. doi: 10.1152/physiolgenomics.00068.2006. [DOI] [PubMed] [Google Scholar]
  34. Riska B, Atchley WR, Rutledge JJ. A genetic analysis of targeted growth in mice. Genetics. 1984;107:79–101. doi: 10.1093/genetics/107.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Robinson MR, English G, Moser G, Lloyd-Jones LR, Triplett MA, Zhu Z, Nolte IM, van Vliet-Ostaptchouk JV, Snieder H, LifeLines Cohort Study. Esko T, Milani L, Mägi R, Metspalu A, Magnusson PKE, Pedersen NL, Ingelsson E, Johannesson M, Yang J, Cesarini D, Visscher PM. Genotype-covariate interaction effects and the heritability of adult body mass index. Nature Genetics. 2017;49:1174–1181. doi: 10.1038/ng.3912. [DOI] [PubMed] [Google Scholar]
  36. Runcie DE, Crawford L. Fast and flexible linear mixed models for genome-wide genetics. PLOS Genetics. 2019;15:e1007978. doi: 10.1371/journal.pgen.1007978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sabatini DM, Barrow RK, Blackshaw S, Burnett PE, Lai MM, Field ME, Bahr BA, Kirsch J, Betz H, Snyder SH. Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling. Science (New York, N.Y.) 1999;284:1161–1164. doi: 10.1126/science.284.5417.1161. [DOI] [PubMed] [Google Scholar]
  38. Salas-Pérez F, Ramos-Lopez O, Mansego ML, Milagro FI, Santos JL, Riezu-Boj JI, Martínez JA. DNA methylation in genes of longevity-regulating pathways: association with obesity and metabolic complications. Aging. 2019;11:1874–1899. doi: 10.18632/aging.101882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sanz R, Ferraro GB, Fournier AE. IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth. The Journal of Biological Chemistry. 2015;290:4330–4342. doi: 10.1074/jbc.M114.628438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schlauch KA, Read RW, Lombardi VC, Elhanan G, Metcalf WJ, Slonim AD, Grzymski JJ, 23andMe Research Team A Comprehensive Genome-Wide and Phenome-Wide Examination of BMI and Obesity in A Northern Nevadan Cohort. G3: Genes, Genomes, Genetics. 2020;10:645–664. doi: 10.1534/g3.119.400910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shim H, Stephens M. Wavelet-based genetic association analysis of functional phenotypes arising from high-throughput sequencing assays. The Annals of Applied Statistics. 2015;9:655–686. doi: 10.1214/14-AOAS776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Singh A. In: Encyclopedia of Behavioral Medicine. Gellman MD, Turner JR, editors. New York: Springer; 2013. Allele Heterogeneity; pp. 66–67. [DOI] [Google Scholar]
  43. Singh K, Loreth D, Pöttker B, Hefti K, Innos J, Schwald K, Hengstler H, Menzel L, Sommer CJ, Radyushkin K, Kretz O, Philips M-A, Haas CA, Frauenknecht K, Lilleväli K, Heimrich B, Vasar E, Schäfer MKE. Neuronal Growth and Behavioral Alterations in Mice Deficient for the Psychiatric Disease-Associated Negr1 Gene. Frontiers in Molecular Neuroscience. 2018;11:30. doi: 10.3389/fnmol.2018.00030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Lango Allen H, Lindgren CM, Luan J, Mägi R, Randall JC, Vedantam S, Winkler TW, Qi L, Workalemahu T, Heid IM, Steinthorsdottir V, Stringham HM, Weedon MN, Wheeler E, Wood AR, Ferreira T, Weyant RJ, Segrè AV, Estrada K, Liang L, Nemesh J, Park J-H, Gustafsson S, Kilpeläinen TO, Yang J, Bouatia-Naji N, Esko T, Feitosa MF, Kutalik Z, Mangino M, Raychaudhuri S, Scherag A, Smith AV, Welch R, Zhao JH, Aben KK, Absher DM, Amin N, Dixon AL, Fisher E, Glazer NL, Goddard ME, Heard-Costa NL, Hoesel V, Hottenga J-J, Johansson A, Johnson T, Ketkar S, Lamina C, Li S, Moffatt MF, Myers RH, Narisu N, Perry JRB, Peters MJ, Preuss M, Ripatti S, Rivadeneira F, Sandholt C, Scott LJ, Timpson NJ, Tyrer JP, van Wingerden S, Watanabe RM, White CC, Wiklund F, Barlassina C, Chasman DI, Cooper MN, Jansson J-O, Lawrence RW, Pellikka N, Prokopenko I, Shi J, Thiering E, Alavere H, Alibrandi MTS, Almgren P, Arnold AM, Aspelund T, Atwood LD, Balkau B, Balmforth AJ, Bennett AJ, Ben-Shlomo Y, Bergman RN, Bergmann S, Biebermann H, Blakemore AIF, Boes T, Bonnycastle LL, Bornstein SR, Brown MJ, Buchanan TA, Busonero F, Campbell H, Cappuccio FP, Cavalcanti-Proença C, Chen Y-DI, Chen C-M, Chines PS, Clarke R, Coin L, Connell J, Day INM, den Heijer M, Duan J, Ebrahim S, Elliott P, Elosua R, Eiriksdottir G, Erdos MR, Eriksson JG, Facheris MF, Felix SB, Fischer-Posovszky P, Folsom AR, Friedrich N, Freimer NB, Fu M, Gaget S, Gejman PV, Geus EJC, Gieger C, Gjesing AP, Goel A, Goyette P, Grallert H, Grässler J, Greenawalt DM, Groves CJ, Gudnason V, Guiducci C, Hartikainen A-L, Hassanali N, Hall AS, Havulinna AS, Hayward C, Heath AC, Hengstenberg C, Hicks AA, Hinney A, Hofman A, Homuth G, Hui J, Igl W, Iribarren C, Isomaa B, Jacobs KB, Jarick I, Jewell E, John U, Jørgensen T, Jousilahti P, Jula A, Kaakinen M, Kajantie E, Kaplan LM, Kathiresan S, Kettunen J, Kinnunen L, Knowles JW, Kolcic I, König IR, Koskinen S, Kovacs P, Kuusisto J, Kraft P, Kvaløy K, Laitinen J, Lantieri O, Lanzani C, Launer LJ, Lecoeur C, Lehtimäki T, Lettre G, Liu J, Lokki M-L, Lorentzon M, Luben RN, Ludwig B, MAGIC. Manunta P, Marek D, Marre M, Martin NG, McArdle WL, McCarthy A, McKnight B, Meitinger T, Melander O, Meyre D, Midthjell K, Montgomery GW, Morken MA, Morris AP, Mulic R, Ngwa JS, Nelis M, Neville MJ, Nyholt DR, O’Donnell CJ, O’Rahilly S, Ong KK, Oostra B, Paré G, Parker AN, Perola M, Pichler I, Pietiläinen KH, Platou CGP, Polasek O, Pouta A, Rafelt S, Raitakari O, Rayner NW, Ridderstråle M, Rief W, Ruokonen A, Robertson NR, Rzehak P, Salomaa V, Sanders AR, Sandhu MS, Sanna S, Saramies J, Savolainen MJ, Scherag S, Schipf S, Schreiber S, Schunkert H, Silander K, Sinisalo J, Siscovick DS, Smit JH, Soranzo N, Sovio U, Stephens J, Surakka I, Swift AJ, Tammesoo M-L, Tardif J-C, Teder-Laving M, Teslovich TM, Thompson JR, Thomson B, Tönjes A, Tuomi T, van Meurs JBJ, van Ommen G-J, Vatin V, Viikari J, Visvikis-Siest S, Vitart V, Vogel CIG, Voight BF, Waite LL, Wallaschofski H, Walters GB, Widen E, Wiegand S, Wild SH, Willemsen G, Witte DR, Witteman JC, Xu J, Zhang Q, Zgaga L, Ziegler A, Zitting P, Beilby JP, Farooqi IS, Hebebrand J, Huikuri HV, James AL, Kähönen M, Levinson DF, Macciardi F, Nieminen MS, Ohlsson C, Palmer LJ, Ridker PM, Stumvoll M, Beckmann JS, Boeing H, Boerwinkle E, Boomsma DI, Caulfield MJ, Chanock SJ, Collins FS, Cupples LA, Smith GD, Erdmann J, Froguel P, Grönberg H, Gyllensten U, Hall P, Hansen T, Harris TB, Hattersley AT, Hayes RB, Heinrich J, Hu FB, Hveem K, Illig T, Jarvelin M-R, Kaprio J, Karpe F, Khaw K-T, Kiemeney LA, Krude H, Laakso M, Lawlor DA, Metspalu A, Munroe PB, Ouwehand WH, Pedersen O, Penninx BW, Peters A, Pramstaller PP, Quertermous T, Reinehr T, Rissanen A, Rudan I, Samani NJ, Schwarz PEH, Shuldiner AR, Spector TD, Tuomilehto J, Uda M, Uitterlinden A, Valle TT, Wabitsch M, Waeber G, Wareham NJ, Watkins H, Procardis Consortium. Wilson JF, Wright AF, Zillikens MC, Chatterjee N, McCarroll SA, Purcell S, Schadt EE, Visscher PM, Assimes TL, Borecki IB, Deloukas P, Fox CS, Groop LC, Haritunians T, Hunter DJ, Kaplan RC, Mohlke KL, O’Connell JR, Peltonen L, Schlessinger D, Strachan DP, van Duijn CM, Wichmann H-E, Frayling TM, Thorsteinsdottir U, Abecasis GR, Barroso I, Boehnke M, Stefansson K, North KE, McCarthy MI, Hirschhorn JN, Ingelsson E, Loos RJF. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genetics. 2010;42:937–948. doi: 10.1038/ng.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Steinsaltz D, Dahl A, Wachter KW. On Negative Heritability and Negative Estimates of Heritability. Genetics. 2020;215:343–357. doi: 10.1534/genetics.120.303161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sul JH, Bilow M, Yang WY, Kostem E, Furlotte N, He D, Eskin E. Accounting for Population Structure in Gene-by-Environment Interactions in Genome-Wide Association Studies Using Mixed Models. PLOS Genetics. 2016;12:e1005849. doi: 10.1371/journal.pgen.1005849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Svenson KL, Gatti DM, Valdar W, Welsh CE, Cheng R, Chesler EJ, Palmer AA, McMillan L, Churchill GA. High-resolution genetic mapping using the Mouse Diversity outbred population. Genetics. 2012;190:437–447. doi: 10.1534/genetics.111.132597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Vauti F, Goller T, Beine R, Becker L, Klopstock T, Hölter SM, Wurst W, Fuchs H, Gailus-Durner V, de Angelis MH, Arnold H-H. The mouse Trm1-like gene is expressed in neural tissues and plays a role in motor coordination and exploratory behaviour. Gene. 2007;389:174–185. doi: 10.1016/j.gene.2006.11.004. [DOI] [PubMed] [Google Scholar]
  49. Vorobyev A, Gupta Y, Sezin T, Koga H, Bartsch YC, Belheouane M, Künzel S, Sina C, Schilf P, Körber-Ahrens H, Beltsiou F, Lara Ernst A, Khil’chenko S, Al-Aasam H, Manz RA, Diehl S, Steinhaus M, Jascholt J, Kouki P, Boehncke W-H, Mayadas TN, Zillikens D, Sadik CD, Nishi H, Ehlers M, Möller S, Bieber K, Baines JF, Ibrahim SM, Ludwig RJ. Gene-diet interactions associated with complex trait variation in an advanced intercross outbred mouse line. Nature Communications. 2019;10:4097. doi: 10.1038/s41467-019-11952-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wang H, Zhang F, Zeng J, Wu Y, Kemper KE, Xue A, Zhang M, Powell JE, Goddard ME, Wray NR, Visscher PM, McRae AF, Yang J. Genotype-by-environment interactions inferred from genetic effects on phenotypic variability in the UK Biobank. Science Advances. 2019;5:eaaw3538. doi: 10.1126/sciadv.aaw3538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. American Journal of Human Genetics. 2011;88:76–82. doi: 10.1016/j.ajhg.2010.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yengo L, Sidorenko J, Kemper KE, Zheng Z, Wood AR, Weedon MN, Frayling TM, Hirschhorn J, Yang J, Visscher PM, GIANT Consortium Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Human Molecular Genetics. 2018;27:3641–3649. doi: 10.1093/hmg/ddy271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zhang G, Deighan A, Raj A, Robinson L, Donato HJ, Garland G, Leland M, Martin-McNulty B, Kolumam GA, Riegler J, Freund A, Wright KM, Churchill GA. Intermittent fasting and caloric restriction interact with genetics to shape physiological health in mice. Genetics. 2022;220:iyab157. doi: 10.1093/genetics/iyab157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zhou X, Stephens M. Genome-wide efficient mixed-model analysis for association studies. Nature Genetics. 2012;44:821–824. doi: 10.1038/ng.2310. [DOI] [PMC free article] [PubMed] [Google Scholar]

Editor's evaluation

Sara Hägg 1

This is an outstanding dissection of the genetic architecture of body weight at the genome-wide level across time and across environments. The use of a multiparental mouse population permits high-resolution mapping. The statistical analyses are advanced, leveraging new models, as well as tools developed specifically for this mouse population. The corresponding results are presented in nice and informative figures.

Decision letter

Editor: Sara Hägg1
Reviewed by: Andrew Dahl2, Amelie Boud3

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Decision letter after peer review:

Thank you for submitting your article "Age and diet shape the genetic architecture of body weight in Diversity Outbred mice" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Matt Kaeberlein as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Andrew Dahl (Reviewer #2); Amelie Baud (Reviewer #3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Wright et al., have empirically studied the subtleties of the genetic architecture of a classic quantitative trait, body weight, providing evidence of gene-by-age and gene-by-diet effects, both at the level of the entire genome and at the level of individual genetic loci. The authors also identified likely causal variants at individual loci. To do so, they used a mouse population descended from multiple, known founders and reconstructed the founder haplotypes at each locus, and also used genomic annotations. Finally, the authors also explored pleiotropy, allelic heterogeneity and locus heterogeneity at the associated loci.

This is an outstanding dissection of the genetic architecture of a complex trait at the genome-wide level, at the locus level, across time and across environments. The experimental design is excellent, with the use of a multiparental mouse population that also permits high-resolution mapping. The statistical analyses are good and advanced, leveraging the GxEMM model recently published by Dahl et al., as well as tools developed specifically for this mouse population to trace back the origin of each QTL to the progenitors of the population; the corresponding results are presented in very informative figures. Finally, the paper is well structured and written, however, additional clarifications, justifications and possibly small additional analyses are requested to make the paper a better fit to the eLife community.

Major Comments:

1. Please justify the p-value thresholds:

– Lines 306-7 say that a 10fold weaker threshold is used for the interaction test--why? Also, where do these thresholds come from?

– Is it sound to take this two-step approach of first finding loci and then 'fine mapping' variants nearby? It is definitely fine if the thresholds are valid genome-wide--but then why not test genome-wide?

2. Please eliminate nonnegativity constraints on VCs in software:

– Are you truncating estimates to be nonnegative? If so, this will cause bias, which I believe is visible in your simulations. This is essential to fix for testing, and also for unbiased VC estimates.

– Users will test random effects, so it is necessary to validate (or remove) this part of your software.

– I don't see an assessment of tests or ses for the VCs. A quick supp figure corresponding to the current simulations would suffice, I think.

3. Please assess standard errors/false positive rates/power for testing VCs:

– Are there evidence that GxEMM improves power for fixed effect interaction tests? I think just commenting on this is enough, but it does seem important if you want others to use your approach. Comparing power (or some measure of false positives) for EMMA vs GxEMM in real data and/or simulation would work.

4. Mouse phenotyping:

– the text needs to say upfront that the mice included in this study were subject to a battery of phenotyping beyond weighing, including metabolic cage phenotyping, blood drwas, and "challenge-based phenotyping procedures". Currently this information comes late in the text (L287), and the title of Figure 1 Supplement 1 reads "Raw phenotype measurements", which does not alert the reader to these additional phenotypes. Some details about this phenotyping are needed, in particular how many blood draws were taken and which specific procedures are included under "challenge-based phenotyping".

This extra phenotyping means that the body weight results presented in this study could be study-specific. In particular, the decrease in PVE observed with age in this study, which contrasts with increased heritability with age observed in previous studies (see Introduction), could be the result of increased noise due to extra phenotyping. The implications of this extra phenotyping need to be discussed.

Importantly, it does not mean that this study is any less relevant than mouse studies without challenging life events, humans also experience challenging life events

5. Clarifications on Figure 4:

– What do PVE_tot and PVE_e represent (more on this below)? In particular, L291 "total genetic variance for the 40% CR group" is non-sensical to me because I thought PVE_tot was across all mice – as suggested by the fact that there is a single dark grey line in Figure 4 showing PVE_tot. Also, I was expecting PVE_tot (dark grey line in Figure 4) to be the sum of non diet-dependent genetic effects + all 5 PVE_e (colored lines). Yet the dark grey line is below the coloured lines. Hence I don't have the right intuition for what PVE_tot and PVE_e are. Looking at the equations didn't help: shouldn't it be PVE_e in Equation (7) and PVE_tot in Equation (13)?

Clarifications are needed.

– Figure 4: I love this figure, but worry a bit about the role of GxGeneration:

– The legend gave me a strong (and wrong) sense that the GxE was all about diet. If possible, disentangling the two GxE contributions visually would be helpful.

– I don't understand why generation is included (eg you could instead include cage effects, or neither).

– Why not have an apples-to-apples comparison using GxGeneration as the baseline for questions about GxDiet?

– What is dark grey? The hom estimate from GxEMM? The hom+GxGeneration (but then shouldn't there be one estimate for each generation)?

– More generally, I don't follow how generation is being used in this paper. Is it just always in the background as a random effect, and if so, why? Why don't you test for locus-x-generation effects--if they're not expected to be interesting, why do they explain so much variance? If they are absorbing confounding, why not also adjust for cage (perhaps with the GxEMM 'IID' model to save degrees of freedom)? I suspect whatever you're doing is reasonable, but maybe just explain a bit more clearly.

Figure 4—figure supplement 2, (b), right – isn't it concerning that the permuted phenotypes are heritable? How can this be? I recognize you don't use this kinship in your real analyses (though believe you do use the genotypes from which the kinship is built), but some explanation here would increase confidence in the overall approach.

I'd like to see versions of Figure 4 that: overlay the interventions, as in supplement Figure 1; only show the E-specific genetic variances (ie substracting the sig2g_hom terms); and show the heritabilities (ie normalize by total variance at each time point). These would make nice supplement Figures if easy to generate.

6. GWAS-related comments:

– The GWAS section and the corresponding figures are overwhelming. I think it would benefit from shortening and using sub-headings. I think it would be good to show first how likely causal variants can be identified (including FAP groups, functional annotations etc. and have one figure for that), with the chr6 and chr 12 loci as examples, and THEN show these loci across age and diets to discuss pleiotropy and heterogeneity.

– except if we consider triallelic SNPs, the distinction between allelic heterogeneity ("a single locus harboring multiple functional alleles each with distinct phenotypic effects") and (what I call locus heterogeneity) "a single genomic region contains multiple functional body weight loci that are only revealed with sufficient fine-mapping resolution" (L346-349) is difficult to make because noise can blur genetic associations, making it impossible to know the exact position of the causal variant(s). Consistent with the difficulty I just mentioned, in the section L419-443 and corresponding Supplementary Figures, I find that the assignments of the loci to either allelic or locus heterogeneity not obvious/robust.

I think it would be best to focus on distinguishing between pleiotropy (same causal variant(s) affecting body weight at different ages or in different diets) and non-pleiotropy (be it allelic or locus heterogeneity), rather than trying to distinguish between allelic and locus heterogeneity.

Statistical tests exist to test the null hypothesis {same locus affects both traits} in multiparental populations (doi.org/10.1534/g3.119.400098). In addition, looking at the FAPs of the lead variants, as the authors do here, would be a great way to complement this statistical test. Statistical evidence of different loci + differing top FAPS would provide strong evidence for some form of heterogeneity.

If you are going to focus on pleiotropy yes/no, it would be good to show a locus with likely pleiotropic effects (with the caveat that this would be the null hypothesis so not really evidence, rather suggestive).

An idea now, not a request: It would be interesting to know whether the loci for which different causal variants are predicted to affect different traits (e.g. different ages) are also loci for which multiple causal variants are predicted to affect either trait (see doi:10.1038/ng.2644).

7. Gene enrichment:

– is there a significant enrichment in genes affecting neurological behavior in this study, to support the claim that the fine-mapped genes implicate neurological and metabolic processes? If not, probably best to move the corresponding section of the text to the discussion. Also discuss whether the associations between neurological genes and body weight could arise due to the stressful extra phenotyping of the mice (are those associations mostly for ages after the challenge-based phenotyping for example, or are they seen even for ages before that stressful phenotyping?)

[Editors’ note: further revisions were suggested prior to acceptance, as described below.]

Thank you for submitting a revised version of your article "Age and diet shape the genetic architecture of body weight in Diversity Outbred mice" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Matt Kaeberlein as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Andrew Dahl (Reviewer #2); Amelie Baud (Reviewer #3).

The manuscript has improved since last submission, however, few comments many for clarity need to be addressed before the manuscript can be accepted for publication.

Essential Revisions:

1) The methods used to calculate the genome-wide significance threshold for the GWAS are now explained with sufficient detail but I believe the thresholds used are much less stringent than commonly accepted (commonly accepted = some estimate of a genome-wide threshold of 0.05). Two lines of evidence for this:

– The authors "used the number of top singular values that explain at least 90% of variation across markers (500), as a proxy for the number of independent QTL signals,", from which they calculated the Bonferroni corrected threshold. They mention in their response to the reviewers that this approach is similar to what is used in human GWAS. However, based on the results presented in Table 1 of https://onlinelibrary.wiley.com/doi/epdf/10.1002/gepi.20430 for example, I believe a value much greater than 90% of variation needs is used when applying this approach to human GWAS data to get close to the commonly accepted threshold of 5.10-8. SimpleM (presented in Table 1 of the paper above) uses a cutoff of 99.5% and still yields a more lenient threshold than 5.10-8.

– Other GWAS in DO mice have used much more stringent thresholds than p-value of 10-4: for example, https://link.springer.com/article/10.1007/s00335-018-9745-8#Sec11 used a P value threshold of 7.3.10-7 to claim genome-wide significance at 0.05; https://reader.elsevier.com/reader/sd/pii/S0168952519300654?token=DEFE149F2C71C5E4EA274AB6AE3638597EEACA678E9451C00AEE8CCD806BDA0E20ACE4BAA8DEF5D6BE37F274132E9F61&originRegion=eu-west-1&originCreation=20210602135101 used an even more stringent threshold – see Figure 3C.

As a consequence of the likely very lenient significance thresholds used in GWAS, all the claims from GWAS and subsequent analyses are supported by limited statistical evidence. In particular, it is difficult to be confident that the apparent lack of pleiotropic signals observed across loci is a real feature of the architecture of body weight: the different FAPs observed etc. could be the result of noise. The genes identified in Table 1 are also supported by limited statistical evidence.

2) I find the GWAS-related text still poorly organised and overwhelming. For example, effects as a function of age are discussed in three different sections (L404, L454, and L483). Similarly pleiotropy is discussed in three different sections, and functional variants are discussed in different sections too. Perhaps group everything related to pleiotropy in one section, effects as a function of age in another, and candidate variants/genes in a third?

The non-linearity in diet is hard to understand and appreciate in the current manuscript. It is quite interesting (surprising), if true. Perhaps give it its own section?

3) Using a diagonal omega matrix is problematic not only for pairs of diets but also for pairs of generations I think, as interaction effect sizes could well be correlated in pairs of generations. The response from the authors to this issue is not entirely satisfactory to me, as they acknowledge that biases are possible but suggest biases will be small without really explaining why they will be small.

– Lines 291-5 – I don't understand why permutations don't fully break the correspondence between both sources of relatedness and phenotype? The kinship is just a matrix, and I don't see how substructures in this matrix could be invariant to random permutation. (You are mean centering such that row/column sums are 0, right? this is required for REML). In other words, what null are you testing if the permutations are also significant? Why doesn't your claim imply that a pure noise phenotype would have significant GxE?

4) For negative VC estimates -- the new supp Figure is great, as is the new flag, but don't see these mentioned in the text? I suggest you acknowledge your constrained approach causes bias (cf your simulations), but that you address it in principle with the new flag and also there is no reason to worry about your real data analyses (because you have such strong signals). I think it's important to have unbiased inference for GxE h2 (much more than for additive h2).

eLife. 2022 Jul 15;11:e64329. doi: 10.7554/eLife.64329.sa2

Author response


Major Comments:

1. Please justify the p-value thresholds:

– Lines 306-7 say that a 10fold weaker threshold is used for the interaction test--why? Also, where do these thresholds come from?

The Bonferroni corrected p-value threshold used in the manuscript is a genome-wide threshold and was computed based on the expected number of linkage disequilibrium (LD) blocks (independent signals) in our study (similar to the strategy used in human GWAS studies). If the LD structure is perfectly block-like, the number of LD blocks can be computed from the number of non-zero singular values of the marker genotype matrix. In practice, we used the number of top singular values that explain at least 90% of variation across markers (500), as a proxy for the number of independent QTL signals, resulting in a p-value threshold of 10-4. This same threshold is reasonable for our interaction tests since we have only one test per marker (similar to the additive tests); however, we use a weaker threshold of 10-3 for interaction tests to explore suggestive GxE interaction QTLs. Our choice of thresholds, although arbitrary, are intended to help us focus our attention to the strongest QTLs with sufficient statistical support and are not intended to quantify the exact number of QTLs linked to body weight. We have updated the manuscript to better explain our choice of p-value thresholds.

– Is it sound to take this two-step approach of first finding loci and then 'fine mapping' variants nearby? It is definitely fine if the thresholds are valid genome-wide--but then why not test genome-wide?

The p-value thresholds we used are valid genome-wide and it is certainly reasonable to simply test genome-wide. We chose to take the two-step approach for two reasons:

1. At the genotyped markers, testing for association between founder-of-origin and phenotype has higher power than testing for association between allele count and phenotype (PMC4169154, PMC3149489). Notably, we only have informative founder-of-origin inferences at genotyped markers.

2. The two-step approach is much more computationally efficient. While this two-step approach certainly has an increased false-negative rate, evaluating the tests longitudinally through age should mitigate this substantially.

2. Please eliminate nonnegativity constraints on VCs in software:

– Are you truncating estimates to be nonnegative? If so, this will cause bias, which I believe is visible in your simulations. This is essential to fix for testing, and also for unbiased VC estimates.

– Users will test random effects, so it is necessary to validate (or remove) this part of your software.

– I don't see an assessment of tests or ses for the VCs. A quick supp figure corresponding to the current simulations would suffice, I think.

Thank you for bringing to our attention the possibility that variance components do not need to be constrained to be positive, in order to have valid estimates of heritability. We re-computed the PVE estimates for all ages and diets without truncating the estimates to be non-negative, and found very little difference in the magnitude and trends of PVE with age (see Figure 4 —figure supplement 4). We chose to keep the estimates with non-negativity constraints as the main result, since these variance components are more interpretable in the context of our study. We have, however, included an option in the software to relax the non-negativity constraints on the variance components.

3. Please assess standard errors/false positive rates/power for testing VCs:

– Are there evidence that GxEMM improves power for fixed effect interaction tests? I think just commenting on this is enough, but it does seem important if you want others to use your approach. Comparing power (or some measure of false positives) for EMMA vs GxEMM in real data and/or simulation would work.

To address the question of power for both fixed effect additive and interaction tests, we performed QTL mapping using the EMMA model, at the same set of ages as for the GxEMM model. In order to compare the GxEMM results to the standard linear mixed model, we reran the body weight association analyses at all ages using the EMMA model. We found that for both the additive and interaction models, at p-value thresholds of 10-3 and 10-4, the EMMA model identified more loci associated with body weight, quantified both by the number of independent genomic regions and average length of time in days per locus. We have updated the Results section, included Figure 5 —figure supplement 2 , and added a table in Supplementary file 3 to highlight this point.

We, however, do not claim the difference in QTLs to be due to a difference in power nor label any model-specific QTLs as false positives. Comparing Figure 5 —figure supplements 1 and 2, we observe that it is rare for a strong association under one model to be completely ablated under the other model; instead we observe subtle differences in likelihood ratio and p-values. Given the high temporal resolution in phenotype measurements, we feel it is more informative to focus on the effect size estimates (and longitudinal trends therein) of reasonably significant QTLs rather than focusing on the (admittedly arbitrarily and binary) problem of testing for QTLs. We relied on GxEMM since it is a more expressive model and EMMA is a special case of GxEMM.

4. Mouse phenotyping:

– The text needs to say upfront that the mice included in this study were subject to a battery of phenotyping beyond weighing, including metabolic cage phenotyping, blood drwas, and "challenge-based phenotyping procedures". Currently this information comes late in the text (L287), and the title of Figure 1 Supplement 1 reads "Raw phenotype measurements", which does not alert the reader to these additional phenotypes. Some details about this phenotyping are needed, in particular how many blood draws were taken and which specific procedures are included under "challenge-based phenotyping".

This is a good point and we have updated the ‘Data’ section to describe the challenge-based phenotyping procedures (L129 – L134).

This extra phenotyping means that the body weight results presented in this study could be study-specific. In particular, the decrease in PVE observed with age in this study, which contrasts with increased heritability with age observed in previous studies (see Introduction), could be the result of increased noise due to extra phenotyping. The implications of this extra phenotyping need to be discussed.

Importantly, it does not mean that this study is any less relevant than mouse studies without challenging life events, humans also experience challenging life events

Agreed; for this reason – and for all the unmeasured factors that we are unaware of – some of these results may be specific to this study. With data from another dietary intervention study in aged, outbred mice, we could assess whether this is the case. We have added text to the ‘Discussion’ to highlight this point (L557 – L559).

5. Clarifications on Figure 4:

– What do PVE_tot and PVE_e represent (more on this below)? In particular, L291 "total genetic variance for the 40% CR group" is non-sensical to me because I thought PVE_tot was across all mice – as suggested by the fact that there is a single dark grey line in Figure 4 showing PVE_tot. Also, I was expecting PVE_tot (dark grey line in Figure 4) to be the sum of non diet-dependent genetic effects + all 5 PVE_e (colored lines). Yet the dark grey line is below the coloured lines. Hence I don't have the right intuition for what PVE_tot and PVE_e are. Looking at the equations didn't help: shouldn't it be PVE_e in Equation (7) and PVE_tot in Equation (13)?

Clarifications are needed.

PVEtot is computed using all mice (dark grey line in Figure 4) and PVEe is computed using mice belonging to diet ‘e’ (colored lines in Figure 4). Since PVEtot and PVEe (for each diet) are computed on different sets of mice, we can’t expect PVEtot to be the sum of all PVEe (i.e., the denominators are different). This is clear from the equations: the denominator of Equation 7 for PVEtot is VarY , the phenotypic variance computed using all the samples, while the denominator of Equation 13 for PVEe is VarY|e , the variance computed using only samples belonging to diet ‘e’. Crucially, PVEe is not the fraction of PVEtot contributed by diet ‘e’.

Thank you for pointing out the error on L291; we have removed the term “total” from that sentence.

– Figure 4: I love this figure, but worry a bit about the role of GxGeneration:

– The legend gave me a strong (and wrong) sense that the GxE was all about diet. If possible, disentangling the two GxE contributions visually would be helpful.

– I don't understand why generation is included (eg you could instead include cage effects, or neither).

– Why not have an apples-to-apples comparison using GxGeneration as the baseline for questions about GxDiet?

– More generally, I don't follow how generation is being used in this paper. Is it just always in the background as a random effect, and if so, why? Why don't you test for locus-x-generation effects--if they're not expected to be interesting, why do they explain so much variance? If they are absorbing confounding, why not also adjust for cage (perhaps with the GxEMM 'IID' model to save degrees of freedom)? I suspect whatever you're doing is reasonable, but maybe just explain a bit more clearly.

The GxEMM model includes variance components for interaction terms with ‘diet’ and ‘generation’. In our study design, ‘generation’ is a proxy for the shared environment that the mice are exposed to throughout the study; in particular, mice of the same generation are subject to various phenotyping pipelines together. In this sense, ‘generation’ effects are essentially batch effects. We chose to always control for GxGeneration random effects in the model since this helped give us better and more precise estimates for PVEe. We don’t test for GxGeneration fixed effects, both because they are not expected to be interesting and because their contribution to diet-dependent PVE values are relatively small (see Figure 4 —figure supplement 5).

PVEe is computed using mice on diet ‘e’ and includes contributions from the diet ‘e’ term and from all the ‘generation’ terms. Thus, PVEe for two diets does have some shared components coming from the generation variance components; however, it is difficult to decompose which parts are truly shared and which are diet-specific, since the PVE are computed on different sets of mice, and thus the contribution of kinship is slightly different (see Equation 14). We have added Figure 4 —figure supplement 4 highlighting the contribution of diet-specific variance components and generation-specific variance components for each PVEe.

We could certainly control for GxCage effects, either assuming the same variance component for all cages as in the GxEMM ‘IID’ model or using a hierarchical model for the cage variance components. Assuming that all cages shared the same variance component parameter, we observed that the estimate for the cage-specific variance components was negligibly small, suggesting that either cage effects were negligible or the ‘IID’ model is too restrictive. A hierarchical model for cage effects is an interesting avenue for future work, but is out of the scope for our current study.

– What is dark grey? The hom estimate from GxEMM? The hom+GxGeneration (but then shouldn't there be one estimate for each generation)?

Dark grey in Figure 4 is the PVE computed using all mice. This includes the contribution from all the diet-specific and generation-specific variance components. We have included Figure 4 —figure supplement 5 showing the contribution of each of these components to the dark grey line.

Figure 4—figure supplement 2, (b), right – isn't it concerning that the permuted phenotypes are heritable? How can this be? I recognize you don't use this kinship in your real analyses (though believe you do use the genotypes from which the kinship is built), but some explanation here would increase confidence in the overall approach.

The SNP-based kinship can be decomposed into two components: the genetic sharing between the founder strains (the 8 founders have some degree of genetic similarity amongst themselves at the SNP level) and the genetic sharing arising from the breeding strategy used to develop the DO panel. In other words, SNP-based kinship accounts for sharing due to identity-by-state while FAP-based kinship accounts for sharing due to identity-by-descent. Randomly permuting the phenotype labels breaks the link between phenotypic similarity and the latter component of SNP-based kinship, but does not effectively break the link with the former component. Computing kinship using the founder allele probability effectively controls for any genetic similarity between the founder strains (i.e., it explicitly only includes the latter component). We believe this explains the inflation of PVE after permuting phenotypes with the SNP-based kinship, observed both for the EMMA and GxEMM models. Based on this reasoning, we hypothesize that the observed inflation would have been worse at earlier generations of DO mice and predict that this inflation will continue to decrease with future generations of DO mice. We have added text in the manuscript elaborating on this observation.

I'd like to see versions of Figure 4 that: overlay the interventions, as in supplement Figure 1; only show the E-specific genetic variances (ie substracting the sig2g_hom terms); and show the heritabilities (ie normalize by total variance at each time point). These would make nice supplement Figuresif easy to generate.

We have added Figure 4 —figure supplement 2, overlaying the interventions onto the PVE trends. We have also added Figure 4 —figure supplement 5 breaking down each PVE (total and diet-dependent) into contributions from the diet-specific terms and the generation-specific terms.

6. GWAS-related comments:

– The GWAS section and the corresponding figures are overwhelming. I think it would benefit from shortening and using sub-headings. I think it would be good to show first how likely causal variants can be identified (including FAP groups, functional annotations etc. and have one figure for that), with the chr6 and chr 12 loci as examples, and THEN show these loci across age and diets to discuss pleiotropy and heterogeneity.

We appreciate the comments from this reviewer and agree that the GWAS section as originally constructed was overwhelming. To address this, we have now broken this section up into two subsections and eliminated the confusing discussion about distinguishing between pleiotropy, allelic heterogeneity and tightly linked loci (see below). We believe these changes will greatly increase reader comprehension.

In regards to figure 5, we agree there is a lot of information in each subpanel. We have re-organized these results into two figures to first discuss the identification of focal variants and second the effect of a focal variant on body weight at different ages.

– except if we consider triallelic SNPs, the distinction between allelic heterogeneity ("a single locus harboring multiple functional alleles each with distinct phenotypic effects") and (what I call locus heterogeneity) "a single genomic region contains multiple functional body weight loci that are only revealed with sufficient fine-mapping resolution" (L346-349) is difficult to make because noise can blur genetic associations, making it impossible to know the exact position of the causal variant(s). Consistent with the difficulty I just mentioned, in the section L419-443 and corresponding Supplementary Figures, I find that the assignments of the loci to either allelic or locus heterogeneity not obvious/robust.

I think it would be best to focus on distinguishing between pleiotropy (same causal variant(s) affecting body weight at different ages or in different diets) and non-pleiotropy (be it allelic or locus heterogeneity), rather than trying to distinguish between allelic and locus heterogeneity.

Yes, this is a good point. We agree that in general we do not have a large enough mapping population for the fine-mapping analysis to distinguish between allelic and locus heterogeneity. We have updated the language in the manuscript to state that these results are not consistent with a single pleiotropic locus.

Statistical tests exist to test the null hypothesis {same locus affects both traits} in multiparental populations (doi.org/10.1534/g3.119.400098). In addition, looking at the FAPs of the lead variants, as the authors do here, would be a great way to complement this statistical test. Statistical evidence of different loci + differing top FAPS would provide strong evidence for some form of heterogeneity.

If you are going to focus on pleiotropy yes/no, it would be good to show a locus with likely pleiotropic effects (with the caveat that this would be the null hypothesis so not really evidence, rather suggestive).

This is a great point. We do not apply this formal test of pleiotropy. We have updated the manuscript to state that when we identify a single FAP associated with body weight at multiple ages (e.g. Figures 6E,F; 7E) that this is suggestive of pleiotropy.

Additionally, we interpret the identification of distinct FAPs at the same genomic region (e.g. chromosome 6 locus with AJ/NOD and B6/CAST/PWK FAPs highlighted in Figures 5 and 6) as strong evidence against a single pleiotropic locus.

An idea now, not a request: It would be interesting to know whether the loci for which different causal variants are predicted to affect different traits (e.g. different ages) are also loci for which multiple causal variants are predicted to affect either trait (see doi:10.1038/ng.2644).

Yes, we agree this is an interesting idea to pursue in follow-up analyses.

7. Gene enrichment:

– is there a significant enrichment in genes affecting neurological behavior in this study, to support the claim that the fine-mapped genes implicate neurological and metabolic processes? If not, probably best to move the corresponding section of the text to the discussion. Also discuss whether the associations between neurological genes and body weight could arise due to the stressful extra phenotyping of the mice (are those associations mostly for ages after the challenge-based phenotyping for example, or are they seen even for ages before that stressful phenotyping?)

We have not tested for a specific GO term enrichment of neurological and metabolic processes for the candidate genes. In response to this comment, we have edited this section of the results to make clear that we do not claim any specific enrichment of these processes. In keeping with comments from another reviewer, we feel that highlighting these six specific candidate genes (Negr1, Gphn, Trm1-like, Creb5, PI3K-C2.γ, and Edem3) adds significant value to the paper. Moreover, we believe that highlighting these six genes in the Results section immediately following our discussion of the fine-mapping data is the clearest way to convey this information to the reader and we have kept this in the Results section.

We agree with this comment (and previous comments) that this particular result, and nearly any other result we present in the paper could in fact be caused by peculiarities of this experiment rather than the ‘true’ genetic basis of variation in body weight and how that is affected by age and diet. We have emphasized this caveat in the Discussion. Future studies that incorporate longitudinal measurements of body weight in both mice and humans should help identify how much of our results are robust to differences in experimental design.

[Editors’ note: further revisions were suggested prior to acceptance, as described below.]

Essential Revisions:

1) The methods used to calculate the genome-wide significance threshold for the GWAS are now explained with sufficient detail but I believe the thresholds used are much less stringent than commonly accepted (commonly accepted = some estimate of a genome-wide threshold of 0.05). Two lines of evidence for this:

– The authors "used the number of top singular values that explain at least 90% of variation across markers (500), as a proxy for the number of independent QTL signals,", from which they calculated the Bonferroni corrected threshold. They mention in their response to the reviewers that this approach is similar to what is used in human GWAS. However, based on the results presented in Table 1 of https://onlinelibrary.wiley.com/doi/epdf/10.1002/gepi.20430 for example, I believe a value much greater than 90% of variation needs is used when applying this approach to human GWAS data to get close to the commonly accepted threshold of 5.10-8. SimpleM (presented in Table 1 of the paper above) uses a cutoff of 99.5% and still yields a more lenient threshold than 5.10-8.

– Other GWAS in DO mice have used much more stringent thresholds than p-value of 10-4: for example, https://link.springer.com/article/10.1007/s00335-018-9745-8#Sec11 used a P value threshold of 7.3.10-7 to claim genome-wide significance at 0.05; https://reader.elsevier.com/reader/sd/pii/S0168952519300654?token=DEFE149F2C71C5E4EA274AB6AE3638597EEACA678E9451C00AEE8CCD806BDA0E20ACE4BAA8DEF5D6BE37F274132E9F61&originRegion=eu-west-1&originCreation=20210602135101 used an even more stringent threshold – see Figure 3C.

As a consequence of the likely very lenient significance thresholds used in GWAS, all the claims from GWAS and subsequent analyses are supported by limited statistical evidence. In particular, it is difficult to be confident that the apparent lack of pleiotropic signals observed across loci is a real feature of the architecture of body weight: the different FAPs observed etc. could be the result of noise. The genes identified in Table 1 are also supported by limited statistical evidence.

We appreciate the reviewers pointing out evidence from both human GWAS and mouse QTL studies suggesting the need for a more stringent p-value cutoff for claiming significance. While the two papers on GWAS in DO mice used a more stringent p-value threshold to claim genome-wide significance at 0.05, the Yuan et al., paper used a different permutation scheme to generate their null distribution and compute their p-value threshold and the Saul et al., paper does not describe how their threshold was selected.

Following the approach in the Gao et al., paper on Bonferroni correction in human GWAS studies, we computed the eigenvalues of the full linkage disequilibrium matrix among genotyped variants and used the top K eigenvalues that explain Y% of total genetic variation as a proxy for the number of independent tests. For Y = 90, we obtained K = 500, leading to a p-value threshold of 1e-4. For Y = 99.5, we obtained K = 4455, leading to a p-value threshold of 1.1e-5. A Bonferroni correction for multiple hypotheses is considered to be highly conservative, particularly for traits like Body Mass that are known to have a strong genetic component. An alternate and less conservative approach would be to use a p-value threshold corresponding to a fixed, expected number of false discoveries. Using the Benjamini-Hochberg method, a procedure that is expected to be robust to correlations due to linkage disequilibrium, we computed a p-value threshold of 1.2e-4 corresponding to a 10% expected false discovery rate.

Given the high heritability of Body Mass and the availability of longitudinal Body Mass data, we reasoned that it was excessively conservative to rely on a single Bonferroni-based p-value threshold as the only source of statistical evidence. Instead, in Table 1, we listed loci that (i) passed a more liberal Bonferroni threshold (matching the 10% FDR threshold), (ii) were identified as significant at multiple ages, and (iii) were found to be significant using fine-mapping analysis. In order to clarify the strength of evidence based on p-values alone, we marked in Table 1 loci with p-value less than 1.1e-5 with *** (denoting them as highly significant), loci with p-value less than 1e-4 with ** (denoting them as significant), and p-value less than 1e-3 with * (denoting them as suggestive). Multiple sources of evidence supporting these loci suggest that the observed associations and related aspects of the architecture of body weight are not the result of noise.

2) I find the GWAS-related text still poorly organised and overwhelming. For example, effects as a function of age are discussed in three different sections (L404, L454, and L483). Similarly pleiotropy is discussed in three different sections, and functional variants are discussed in different sections too. Perhaps group everything related to pleiotropy in one section, effects as a function of age in another, and candidate variants/genes in a third?

The non-linearity in diet is hard to understand and appreciate in the current manuscript. It is quite interesting (surprising), if true. Perhaps give it its own section?

We have restructured the GWAS-related text to improve readability and organization of information. First, we discussed the use of founder allele patterns, along with functional variants and candidate genes at the two loci we’ve highlighted, then we discussed pleiotropy, and, finally, we discussed effects as a function of age. We have retained a separate, broader discussion on candidate genes that we’ve identified in this study. We have also separated the paragraph on non-linearity in effects with diet into its own section.

3) Using a diagonal omega matrix is problematic not only for pairs of diets but also for pairs of generations I think, as interaction effect sizes could well be correlated in pairs of generations. The response from the authors to this issue is not entirely satisfactory to me, as they acknowledge that biases are possible but suggest biases will be small without really explaining why they will be small.

We acknowledge the lack of explanation behind our intuition that off-diagonal terms in the omega matrix are expected to be small, leading to small biases in estimates of heritability. To address this, we modified our code to estimate a full omega matrix and computed heritability estimates at each age using the full matrix. We observed that off-diagonal entries of the full omega matrix were often orders of magnitude smaller than the diagonal entries, leading to very small changes in heritability estimates using the full matrix. We have added Figure 4 —figure supplement 5 comparing the heritability estimates between a diagonal omega matrix and a full omega matrix.

– Lines 291-5 – I don't understand why permutations don't fully break the correspondence between both sources of relatedness and phenotype? The kinship is just a matrix, and I don't see how substructures in this matrix could be invariant to random permutation. (You are mean centering such that row/column sums are 0, right? this is required for REML). In other words, what null are you testing if the permutations are also significant? Why doesn't your claim imply that a pure noise phenotype would have significant GxE?

The kinship is a matrix of relatedness between pairs of individuals; in this sense, substructures in this matrix (or even the entire kinship matrix) could be invariant to certain permutations of samples depending on whether kinship is computed using genotypes or using founder allele probabilities. This invariance is much more readily observed in the DO mouse population (or other lab-outbred populations) than in natural populations of mice or humans, particularly because the DO population is currently only ~30 generations removed from the inbred Collaborative Cross mouse lines from which they were derived.

As an extreme example, if the mice in our study were composed of just “copies” of the 8 founder strains, then the genotype-based kinship matrix would have eight blocks of matrix-of-ones along the diagonal (since the 8 founders are completely homozygous), with off-diagonal blocks capturing the kinship between pairs of founders. Such a kinship matrix is invariant under certain permutations of sample ids; these permutations would give significant heritability estimates and, thus, straightforward permutations would not be a valid approach to construct a null of no association between genotype and phenotype.

The current DO population matches a less extreme version of the example above, due to ~30 generations of outbreeding. Thus, permuting the genotype-based kinship matrix does not fully break the association between genotype and phenotype. We believe this effect would have been more extreme in earlier DO generations, and will continue to weaken in later DO generations.

4) For negative VC estimates -- the new supp Figure is great, as is the new flag, but don't see these mentioned in the text? I suggest you acknowledge your constrained approach causes bias (cf your simulations), but that you address it in principle with the new flag and also there is no reason to worry about your real data analyses (because you have such strong signals). I think it's important to have unbiased inference for GxE h2 (much more than for additive h2).

We have now addressed in the manuscript the possible bias in our constrained approach, shown that we observed little difference with and without the constraint, and highlighted that our software allows for relaxing this constraint via a flag.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Genotype data: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare. [DOI] [PMC free article] [PubMed]
    2. Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Phenotype data: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare. [DOI] [PMC free article] [PubMed]
    3. Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Results: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare. [DOI] [PMC free article] [PubMed]
    4. Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Covariate data: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare. [DOI] [PMC free article] [PubMed]

    Supplementary Materials

    Transparent reporting form

    Data Availability Statement

    All data used in the study, and results of analyses, are publicly available at https://figshare.com/projects/Age_and_diet_shape_the_genetic_architecture_of_body_weight_in_Diversity_Outbred_mice/92201.

    The following datasets were generated:

    Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Genotype data: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare.

    Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Phenotype data: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare.

    Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Results: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare.

    Wright KM, Deighan A, Di Francesco A, Freund A, Jojic V, Churchill G, Raj A. 2020. Covariate data: Age and diet shape the genetic architecture of body weight in Diversity Outbred mice. figshare.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES